The present disclosure relates to malware detection systems and, more specifically, to verification of exploit or malware at a malware detection system appliance of a network.
Data communication in a network involves the exchange of data between two or more entities interconnected by communication links and sub-networks (segments). The entities are typically software processes executing in operating systems of computers, such as end nodes and intermediate nodes. The intermediate nodes interconnect the communication links and segments to enable transmission of data between the end nodes. A local area network (LAN) is an example of segment that provides relatively short distance communication among the interconnected nodes, whereas a wide area network (WAN) enables long distance communication over links provided by telecommunications facilities. The Internet is an example of a WAN that connects disparate computer networks throughout the world, providing global communication between nodes on various networks.
Malicious software (malware) has become a pervasive problem for nodes coupled to networks, such as the Internet. Malware is often embedded within downloadable content intended to adversely influence or attack normal operations of a node. Whereas operating system vulnerabilities have traditionally been common targets of such malware content, attackers have broadened their attack to exploit vulnerabilities in processes or applications, such as web browsers. For example, malware content may be embedded within objects associated with a web page hosted by a malicious web site.
Various types of security enhanced nodes, such as security appliances, are often deployed at different segments of the networks. These security appliances often employ virtualization systems to provide the enhanced security needed to uncover the presence of malware embedded within ingress content propagating over the different segments. Specifically, detection at the network periphery may be limited by the capability of the malware detection system for precise and effective detection without excessive false positives (wrongly identified attacks) on the one hand (such as is often the case with intrusion detection systems), and for timely analysis of behaviors of the network traffic to completely prevent network intrusion on the other (such as is typically the case with security appliances). Furthermore, the analysis at the network periphery may not provide sufficient information about the particular target or targets (e.g., endpoints) within the network and the potential scope and severity of an attack. Various types of security appliances typically operate without any mutual relationship or correlation among the virtualization systems. Thus, knowledge of malware identities (i.e., signatures) are typically not shared among the virtualization systems, resulting in untimely and inaccurate determination of whether the ingress content includes malware (i.e., re-identify the malware).
The above and further advantages of the embodiments herein may be better understood by referring to the following description in conjunction with the accompanying drawings in which like reference numerals indicate identically or functionally similar elements, of which:
The embodiments herein provide a technique for verifying a determination of an exploit or malware in an object at a malware detection system (MDS) appliance through correlation of activity, i.e., behaviors, of the object running on endpoints of a network. The MDS appliance may be illustratively positioned within the network to intercept communication traffic directed to the endpoints coupled to a segment of the network. The object may be included within, e.g., a payload of a packet associated with the communication traffic. The appliance may analyze the object to render a determination that the object is suspicious and may contain the exploit or malware. In response, the MDS appliance may pull from (e.g., poll) the endpoints or receive a push from (e.g., messages) the endpoints so as to determine whether any of the endpoints may have analyzed the suspect object and observed its behaviors. If the object was analyzed, the endpoints may provide the observed behavior information to the appliance, which may then correlate that information, e.g., against correlation rules, to verify its determination of the exploit or malware. In addition, the appliance may task the endpoints to analyze the object, e.g., during run time, to determine whether it contains the exploit and provide the results to the appliance for correlation. Accordingly, the MDS appliance may verify its determination of an exploit in the object through correlation with the endpoints.
In an embodiment, the appliance may poll a selected group of endpoints in order to collect additional behavior information of the suspect object and correlate that information against a set of correction rules to provide a high level view of the exploit and any potential spreading of the exploit or malware (e.g., as an infection) in the network over the period of time. In another embodiment, the appliance may receive one or more messages from a group of endpoints about the additional behavior information of the suspect object. The set of correlation rules used by the appliance to correlate the behavior information collected from the endpoints may be enhanced to identify a pattern of object activity throughout the network. By collecting additional behavior information from multiple endpoints, the appliance may be provided with a large sampling of sophisticated object activity with which to correlate and obtain a more complete view of the activity pattern. In response to correlation of the behavior information, the appliance may then task one or more endpoints to monitor the suspect object to acquire further behavior information for correlation. The high level view of the exploit and its sophisticated activity and behaviors when running on the endpoints may advantageously enable the appliance to more accurately verify the exploit, e.g., as malware.
In an embodiment, the endpoints may illustratively include, e.g., client/server desktop computers, laptop/notebook computers, process controllers, medical devices, data acquisition devices, mobile devices, such as smartphones and tablet computers, and/or any other intelligent, general-purpose or special-purpose electronic device having network connectivity and, particularly for some embodiments, that may be configured to implement a virtualization system. The nodes 200 illustratively communicate by exchanging packets or messages (i.e., communication traffic) according to a predefined set of protocols, such as the Transmission Control Protocol/Internet Protocol (TCP/IP); however, it should be noted that other protocols, such as the HyperText Transfer Protocol Secure (HTTPS), may be advantageously used with the embodiments herein. In the case of private network 130, the intermediate node 200I may include a firewall or other network device configured to limit or block certain communication (network) traffic in an attempt to protect the endpoints from unauthorized users. Unfortunately, such conventional attempts often fail to protect the endpoints, which may be compromised.
In one or more embodiments where the MDS appliance 200M is communicatively coupled with the network 130, the network interface 214 may operate as a data capturing device (sometimes referred to as a “tap” or “network tap”) that is configured to receive incoming network (data) traffic propagating from public network 120 and into private network 130, and provide at least some of this data traffic or a duplicated copy of the traffic for malware detection. In one embodiment, the MDS appliance may be positioned (deployed) behind the firewall at an ingress point into the private network 130, and at least partially in-line with network devices (e.g., endpoints) so as to capture and analyze the incoming traffic (e.g., through static analysis) and potentially block that traffic which is classified as malware from reaching an internal destination (e.g., the endpoints). In another embodiment, the static analysis may be at least partially performed by the firewall or other intermediate device, or performed by the network interface 214 (e.g., by CPU 212 and/or a digital signal processor on a network interface card).
The memory 220 may include a plurality of locations that are addressable by the CPU(s) 212 and the network interface(s) 214 for storing software program code (including application programs) and data structures associated with the embodiments described herein. The CPU 212 may include processing elements or logic adapted to execute the software program code, such as threat-aware micro-hypervisor 300 as well as modules of malware detection architectures described herein, and manipulate the data structures. Exemplary CPUs may include families of instruction set architectures based on the x86 CPU and the x64 CPU.
An operating system kernel 230, portions of which are typically resident in memory 220 and executed by the CPU, functionally organizes the node by, inter alia, invoking operations in support of the software program code and application programs executing on the node. A suitable operating system kernel 230 may include proprietary and open source operating systems from a variety of commercial vendors or available publicly. Suitable application programs may include internet browsers, document viewers or browsers, word processors, email clients and the like as is known to persons of skill in the art. Illustratively, the software program code may be implemented as operating system processes of the kernel 230. As used herein, a process (e.g., a user mode process) is an instance of software program code (e.g., an application program) executing in the operating system that may be separated (decomposed) into one or more threads, wherein each thread is a sequence of execution within the process.
It will be apparent to those skilled in the art that other types of processing elements and memory, including various computer-readable media, may be used to store and execute program instructions pertaining to the embodiments described herein. Also, while the embodiments herein are described in terms of software program code, processes, and computer, e.g., application, programs stored in memory, alternative embodiments also include the code, processes and programs being embodied as engines and/or modules consisting of hardware, software, firmware, or combinations thereof.
Threat-Aware Micro-Hypervisor
As a light-weight module, the micro-hypervisor 300 may provide a virtualization layer having less functionality than a typical hypervisor. Therefore, as used herein, the micro-hypervisor 300 is a module (component) that underlies the operating system kernel 230 and includes the functionality of a micro-kernel (e.g., protection domains, execution contexts, capabilities and scheduling), as well as a subset of the functionality of a hypervisor (e.g., hyper-calls to implement a virtual machine monitor). Accordingly, the micro-hypervisor may cooperate with a unique virtual machine monitor (VMM), i.e., a type 0 VMM, to provide additional virtualization functionality in an operationally and resource efficient manner. Unlike a type 1 or type 2 VMM (hypervisor), the type 0 VMM (VMM 0) does not fully virtualize the kernel (hardware) resources of the node and supports execution of only one entire operating system/instance inside one virtual machine, i.e., VM. VMM 0 may thus instantiate the VM as a container for the operating system kernel 230 and its kernel resources. In an embodiment, VMM 0 may instantiate the VM as a module having instrumentation logic 360 directed to determination of an exploit or malware in any suspicious operating system process (kernel or user mode). Illustratively, VMM 0 is a pass-through module configured to expose the kernel resources of the node (as controlled by micro-hypervisor 300) to the operating system kernel 230. VMM 0 may also expose resources such as virtual CPUs (threads), wherein there is one-to-one mapping between the number of physical CPUs and the number of virtual CPUs that VMM 0 exposes to the operating system kernel 230. To that end, VMM 0 may enable communication between the operating system kernel (i.e., the VM) and the micro-hypervisor over privileged interfaces 315 and 310.
The VMM 0 may include software program code (e.g., executable machine code) in the form of instrumentation logic 350 (including decision logic) configured to analyze one or more interception points originated by one or more operating system processes to invoke the services, e.g., accesses to the kernel resources, of the operating system kernel 230. As used herein, an interception point is a point in an instruction stream where control passes to (e.g., is intercepted by) either the micro-hypervisor, VMM 0 or another virtual machine. Illustratively, VMM 0 may contain computer executable instructions executed by the CPU 212 to perform operations that initialize and implement the instrumentation logic 350, as well as operations that spawn, configure, and control/implement the VM and its instrumentation logic 360.
In an embodiment, the micro-hypervisor 300 may be organized to include a protection domain illustratively bound to the VM. As used herein, a protection domain is a container for various data structures, such as execution contexts, scheduling contexts, and capabilities associated with the kernel resources accessible by an operating system process. Illustratively, the protection domain may function at a granularity of an operating system process (e.g., a user mode process) and, thus, is a representation of the process. Accordingly, the micro-hypervisor may provide a protection domain for the process and its run-time threads executing in the operating system. A main protection domain (PD 0) of the micro-hypervisor controls all of the kernel resources available to the operating system kernel 230 (and, hence, the user mode process) of the VM via VMM 0 and, to that end, may be associated with the services provided to the user mode process by the kernel 230.
An execution context 320 is illustratively a representation of a thread (associated with an operating system process) and, to that end, defines a state of the thread for execution on CPU 212. In an embodiment, the execution context may include inter alia (i) contents of CPU registers, (ii) pointers/values on a stack, (iii) a program counter, and/or (iv) allocation of memory via, e.g., memory pages. The execution context 320 is thus a static view of the state of thread and, therefore, its associated process. Accordingly, the thread executes within the protection domain associated with the operating system process of which the thread is a part. For the thread to execute on a CPU 212 (e.g., as a virtual CPU), its execution context 320 is tightly linked to a scheduling context 330, which may be configured to provide information for scheduling the execution context 320 for execution on the CPU 212. Illustratively, the scheduling context information may include a priority and a quantum time for execution of its linked execution context on CPU 212.
In an embodiment, the capabilities 340 may be organized as a set of access control permissions to the kernel resources to which the thread may request access. Each time the execution context 320 of a thread requests access to a kernel resource, the capabilities 340 are examined. There is illustratively one set of capabilities 340 for each protection domain, such that access to kernel resources by each execution context 320 (i.e., each thread of an execution context) of a protection domain may be defined by the set of capabilities 340. For example, physical addresses of pages of memory 220 (resulting from mappings of virtual addresses to physical addresses) may have associated access permissions (e.g., read, write, read-write) within the protection domain. To enable an execution context 320 to access a kernel resource, such as a memory page, the physical address of the page may have a capability 340 that defines how the execution context 320 may reference that page. Illustratively, the capabilities may be examined by hardware (e.g., a hardware page fault upon a memory access violation) or by program code. A violation of a capability in a protection domain may be an interception point, which returns control to the VM bound to the protection domain.
Malware Detection Endpoint Architecture
In an embodiment, the threat-aware micro-hypervisor 300 may be deployed in a micro-virtualization architecture as a module of a virtualization system executing on the endpoint 200E to provide exploit and malware detection within the network environment 100.
A system call illustratively provides an interception point at which a change in privilege levels occurs in the operating system, i.e., from a privilege level of the user mode process to a privilege level of the operating system kernel. VMM 0 may intercept the system call and examine a state of the process issuing (sending) the call. The instrumentation logic 350 of VMM 0 may analyze the system call to determine whether the call is suspicious and, if so, instantiate (spawn) one or more “micro” virtual machines (VMs) equipped with monitoring functions that cooperate with the micro-hypervisor to detect anomalous behavior which may be used in determining an exploit or malware.
As used herein, an exploit may be construed as information (e.g., executable code, data, one or more commands provided by a user or attacker) that attempts to take advantage of a computer program or system vulnerability, often employing malware. Typically, a vulnerability may be a coding error or artifact of a computer program that allows an attacker to alter legitimate control flow during processing of the computer program by an electronic device (such as a node) and, thus, causes the electronic device to experience undesirable or unexpected behaviors. The undesired or unexpected behaviors may include a communication-based or execution-based anomaly which, for example, could (1) alter the functionality of the electronic device executing application software in a malicious manner; (2) alter the functionality of the electronic device executing the application software without any malicious intent; and/or (3) provide unwanted functionality which may be generally acceptable in another context. To illustrate, a computer program may be considered a state machine where all valid states (and transitions between states) are managed and defined by the program, in which case an exploit may be viewed as seeking to alter one or more of the states (or transitions) from those defined by the program. Malware may be construed as computer code that is executed by an exploit to harm or co-opt operation of an electronic device or misappropriate, modify or delete data. Conventionally, malware may often be designed with malicious intent, and may be used to facilitate an exploit. For convenience, the term “malware” may be used herein to describe any technique that causes a malicious attack, and encompasses both malicious code and exploits detectable in accordance with the disclosure herein.
As used herein, the term “micro” VM denotes a virtual machine serving as a container that is restricted to a process (as opposed to the VM which is spawned as a container for the entire operating system). Such spawning of a micro-VM may result in creation of an instance of another module (i.e., micro-VM N) that is substantially similar to the VM, but with different (e.g., additional) instrumentation logic 360N illustratively directed to determination of an exploit or malware in the suspicious process by, e.g., monitoring its behavior. In an embodiment, the spawned micro-VM illustratively encapsulates an operating system process, such as a user mode process 410. A micro-VM may also be embodied as a memory view (as described herein). In terms of execution, operation of the process is controlled and synchronized by the operating system kernel 230; however, in terms of access to kernel resources, operation of the encapsulated process is controlled by VMM 0. Notably, the resources appear to be isolated within each spawned micro-VM such that each respective encapsulated process appears to have exclusive control of the resources. In other words, access to kernel resources is synchronized among the micro-VMs and the VM by VMM 0 rather than virtually shared. Similar to the VM, each micro-VM may be configured to communicate with the micro-hypervisor (via VMM 0) over privileged interfaces (e.g., 315n and 310n).
Whereas a micro-VM may be restricted to a guest process, the hardware resources used by that micro-VM, such as memory, may be accessed by a plurality of micro-VMs (and their respective guest processes). As noted, there is only one virtual machine (e.g., the VM) per guest operating system on the endpoint. Typically, the guest operating system running in the VM has one “view” of the memory 220, i.e., “guest-physical” memory (memory appearing as physical within the VM), corresponding to a memory management unit page table of the CPU 212 that provides access to the guest-physical memory as seen by that guest operating system running in the VM. Accordingly, a same page table (i.e., memory view) may be used by a plurality of guest processes, each contained in a separate corresponding micro-VM (i.e., memory view) that uses a same page table. However, additional views of memory may be created for each guest process, such as where every view corresponds to a different (i.e., separate) nested page table. Thus, different guest processes may view the guest-physical memory differently (e.g., with different translations or different permissions to the actual memory 220).
In an embodiment, the privileged interfaces 310 and 315 may be embodied as a set of defined hyper-calls, which are illustratively inter process communication (IPC) messages exposed (available) to VMM 0 and the VM (including any spawned micro-VMs). The hyper-calls are generally originated by VMM 0 and directed to the micro-hypervisor 300 over privileged interface 310, although the VM and the micro-VMs may also originate one or more hyper-calls (IPC messages) directed to the micro-hypervisor over privileged interface 315. However, the hyper-calls originated by the VM and the micro-VMs may be more restricted than those originated by VMM 0.
In an embodiment, the micro-hypervisor 300 may be organized to include a plurality of protection domains (e.g., PD 0-N) illustratively bound to the VM and one or more micro-VMs, respectively. For example, the spawned micro-VM (e.g., micro-VM N) is illustratively associated with (bound to) a copy of PD 0 (e.g., PD N) which, in turn, may be bound to the process, wherein such binding may occur through memory context switching. In response to a decision to spawn the micro-VM N, VMM 0 may issue a hyper-call over interface 310 to the micro-hypervisor requesting creation of the protection domain PD N. Upon receiving the hyper-call, the micro-hypervisor 300 may copy (i.e., “clone”) the data structures (e.g., execution contexts, scheduling contexts and capabilities) of PD 0 to create PD N for the micro-VM N, wherein PD N has essentially the same structure as PD 0 except for the capabilities associated with the kernel resources. The capabilities for PD N may limit or restrict access to one or more of the kernel resources as instructed through one or more hyper-calls from, e.g., VMM 0 and/or micro-VM N over interface 310n to the micro-hypervisor. Accordingly, the micro-hypervisor 300 may contain computer executable instructions executed by the CPU 212 to perform operations that initialize, clone and configure the protection domains.
Advantageously, the micro-hypervisor 300 may be organized as separate protection domain containers for the operating system kernel 230 (PD 0) and one or more operating system processes (PD N) to facilitate further monitoring and/or understanding of behaviors of a process and its threads. Such organization of the micro-hypervisor also enforces separation between the protection domains to control the activity of the monitored process. Moreover, the micro-hypervisor 300 may enforce access to the kernel resources through the use of variously configured capabilities of the separate protection domains. Unlike previous virtualization systems, separation of the protection domains to control access to kernel resources at a process granularity enables detection of anomalous behavior of an exploit or malware. That is, in addition to enforcing access to kernel resources, the micro-hypervisor enables analysis of the operation of a process within a spawned micro-VM to detect exploits or other malicious code threats that may constitute malware.
The user mode processes 410 and operating system kernel 230 may execute in the user space 402 of the endpoint architecture 400, although it will be understood to those skilled in the art that the user mode processes may execute in another address space defined by the operating system kernel. Illustratively, the operating system kernel 230 may execute under control of the micro-hypervisor at a privilege level (i.e., a logical privilege level) lower than a highest privilege level of the micro-hypervisor, but at a higher CPU privilege level than that of the user mode processes 410. In addition, VMM 0 and its spawned VMs (e.g., the VM and micro-VM N) may execute in user space 402 of the architecture 400. As a type 0 virtual machine monitor, VMM 0 (and its spawned VM and micro-VMs) may execute at the highest (logical) privilege level of the micro-hypervisor. That is, VMM 0 (and its spawned VM and micro-VMs) may operate under control of the micro-hypervisor at the highest micro-hypervisor privilege level, but may not directly operate at the highest CPU (hardware) privilege level.
Illustratively, the instrumentation logic of VMM 0 (and its spawned micro-VMs) may include monitoring logic configured to monitor and collect capability violations (e.g., generated by CPU 212) in response to one or more interception points to thereby infer an exploit or malware. Inference of an exploit or malware may also be realized through sequences of interception points wherein, for example, a system call followed by another system call having certain parameters may lead to an inference that the process sending the calls is an exploit or malware. The interception point thus provides an opportunity for VMM 0 to perform “light-weight” (i.e., limited so as to maintain user experience at the endpoint with little performance degradation) analysis to evaluate a state of the process in order to detect a possible exploit or malware without requiring any policy enforcement. VMM 0 may then decide to spawn a micro-VM and configure the capabilities of its protection domain to enable deeper monitoring and analysis (e.g., through interception points and capability violations) in order to determine whether the process is an exploit or malware. Notably, the analysis may also classify the process as a type of exploit (e.g., a stack overflow) or as malware and may even identify the same. As a result, the invocation of instrumentation and monitoring logic of VMM 0 and its spawned VMs in response to interception points originated by operating system processes and capability violations generated by the micro-hypervisor advantageously enhance the virtualization system described herein to provide an exploit and malware detection system configured for run-time security analysis of the operating system processes executing on the endpoint.
VMM 0 may also log the state of the monitored process within system logger 470. In an embodiment, the state of the process may be realized through the contents of the execution context 320 (e.g., CPU registers, stack, program counter, and/or allocation of memory) executing at the time of each capability violation. In addition, the state of the process may be realized through correlation of various activities or behavior of the monitored process. The logged state of the process may thereafter be exported from the system logger 470 to the MDS 200M of the network environment 100 by, e.g., forwarding the state as one or more IPC messages through VMM 0 (VM) and onto a network protocol stack (not shown) of the operating system kernel. The network protocol stack may then format the messages as one or more packets according to, e.g., a syslog protocol such as RFC 5434 available from IETF, for transmission over the network to the MDS 200M.
Malware Detection Appliance Architecture
In one or more embodiments, the MDS appliance node (MDS) 200M may be embodied as an intermediate node configured to analyze communication traffic associated with one or more endpoints 200E coupled to a segment of a network, such as private network 130. The MDS appliance 200M may be illustratively positioned (e.g., as an ingress/egress point) within the private network 130 or segment to intercept (i.e., snoop) the traffic. In one or embodiments, the MDS appliance may manage each endpoint by, e.g., requesting processing and instrumentation of the traffic by the endpoint 200E. The intercepted traffic may also be processed and instrumented (i.e., monitored) at the appliance. Thereafter, the instrumented traffic may be correlated at the MDS appliance 200M to communicate the states of instrumentation between the endpoint 200E and appliance. Note that such communication between the endpoint and MDS appliance may occur directly or indirectly via the SIEM acting as an intermediary. To that end, the MDS appliance may be configured to communicate with and instruct the endpoint to, e.g., perform an action and receive notification of that action. In an embodiment the MDS appliance may direct one or more endpoints to spawn a micro-VM having restricted capabilities (i.e., a restrictive memory view) to process and instrument the intercepted traffic and report results back (e.g., communicate collected states) to the MDS appliance. That is, the MDS appliance may determine that the intercepted traffic having a specific signature is potentially malicious and instruct the endpoint to process and instrument traffic matching that signature in a restrictive memory view. An example MDS appliance is described in U.S. patent application Ser. No. 14/962,497 titled Microvisor-Based Malware Detection Appliance Architecture, by Ismael, filed Dec. 8, 2015, which application is hereby incorporated by reference.
Illustratively, the MDS appliance 200M may include functionality directed to processing of communication traffic and correlating instrumentation of that traffic with actions resulting from that traffic at the endpoints. For every network packet received, the appliance may run a heuristic to compute a flow, as appropriate, for the packet, and then create (spawn) a virtual machine (VM) to emulate an endpoint using an image of an operating system (guest operating system and one or more applications) configured to replicate a software processing environment of the endpoint, e.g., based on a payload (object) of the packet to be processed and instrumented. An object may include a logical entity such as, for example, a web page, an email or email attachment, an executable (i.e., binary or script), a file (which may contain an executable), or universal resource locator (URL). Information as to an appropriate processing environment may be provided by the packet itself, e.g., the packet header may identify the packet type, for example, a document such as a Portable Document Format (PDF) document and, thus, the processing environment may include a document reader. Additionally, or in alternative embodiments, information may also be provided by the endpoint (such as the destination endpoint as specified in the packet) to the MDS appliance indicating a type of application software (process) executing within the operating system on the endpoint. The appliance may then launch a copy of the application along with appropriate instrumentation to process each object. For example, assume the MDS appliance process HTTPS traffic received at the endpoint which executes, inter alia, an application (i.e., a web browser). The appliance may capture the communication (HTTPS) traffic destined to the endpoint, spawn the VM and launch a copy of the web browser along with instrumentation to monitor the traffic. Thereafter, the MDS appliance may communicate the state of the instrumentation to the endpoint, depending upon the captured traffic.
In an embodiment, the threat-aware micro-hypervisor 300 may be deployed in a virtualization architecture as a module of a virtualization system executing on the MDS appliance 200M to provide exploit and malware detection within the network environment 100.
One or more hypervisors, e.g., type 1 VMM (e.g., VMM 1), may be disposed as one or more modules over the micro-hypervisor 300 and operate in user space 502 of the architecture 500 under control of the micro-hypervisor at the highest micro-hypervisor privilege level to provide additional layers of virtualization for the MDS appliance 200M. Illustratively, each hypervisor provides full virtualization of kernel (hardware) resources and supports execution of one or more entire operating system instances (i.e., guest operating system) inside one or more full virtual machines. In one or more embodiments, the full virtual machine (VM) may simulate a computer (machine) based on specifications of a hypothetical (abstract) computer or based on an architecture and functions of an actual (real) computer. To that end, a hypervisor (e.g., VMM 1) may instantiate a full VM (e.g., VM 1) as a module provisioned with a software profile that includes a guest operating system (e.g., guest operating system 515) and any associated application programs (e.g., application 525), as well as instrumentation logic (e.g., instrumentation logic 360A) directed to determination of an exploit or malware in any suspicious object or application executing on the guest operating system. Illustratively, the hypervisor may instantiate the full VM from a pool of VMs configured to closely simulate various target operating environments (e.g., software profiles) in which the exploit or malware is to be analyzed. The software profile (e.g., guest operating system and/or application program) provisioned and configured in the VM may be different (e.g., in vendor, type and/or version) from the software profile provisioned and configured in other instantiated VMs (e.g., VM N).
Illustratively, each hypervisor (e.g., VMM 1-1N) may contain computer executable instructions executed by the CPU 212 to perform operations that initialize and configure the instrumentation logic (e.g., instrumentation logic 350A-N), as well as operations that spawn, configure, and control/implement the VM (e.g., VM 1-N) and their instrumentation logic (e.g., 360A-N). In an embodiment, there is illustratively one hypervisor (e.g., VMM 1-1N) for each VM (e.g., VMs 1-N), wherein each VM may be used to emulate an endpoint. The MDS appliance 200M may not emulate every endpoint on the segment, but when a suspicious object (such as, e.g., a file of a network packet) is identified, the VMM 1 of the appliance may create (spawn) a full VM 1 to analyze that object. The virtualization layers of the MDS appliance 200M may cooperate to implement an abstraction of virtual devices exposed as, e.g., virtual network interfaces to the VMs, as opposed to the real network interfaces exposed to the micro-VMs of the endpoint.
The user mode processes 510 executing on the MDS appliance 200M may include a heuristic engine 530 that, in response to receiving communication traffic, is configured to run one or more heuristics to determine whether the traffic (i.e., an object of a packet) is suspicious. Illustratively, the heuristic engine may use pre-defined anomalous characteristics of verified exploits and malware to, e.g., identify communication protocol anomalies and/or suspect source addresses of known malicious servers. For example, the heuristic engine may examine metadata or attributes of the object and/or a code image (e.g., a binary image of an executable) of the object to determine whether a portion of the object matches a predetermined pattern or signature associated with a known type of exploit or malware. The heuristic engine 530 may provide the packet of the suspicious traffic to one or more processes 510 embodied as analysis engine 540. In an embodiment, the analysis engine 540 may be configured to perform static analysis of the object of the packet to, e.g., identify software profile information associated with an operating system instance for execution in a full VM (virtualizing all kernel resources). The analysis engine 540 may also be configured to analyze other content of the packet (e.g., destination address of a network header) to determine its destination (i.e., the endpoints). To that end, the analysis engine 540 may be configured to cooperate with a module, e.g., endpoint (EP) logic 560, to communicate to the endpoints 200E, e.g., to identify and/or acquire information (including the software profile) associated with execution of the exploit or malware on the endpoint. The analysis engine 540 may then provide the software profile information to another process embodied as scheduler 550, which may coordinate with the hypervisor, e.g., VMM 1, to spawn a VM, e.g., VM 1, to process the traffic. Note that the MDS appliance may instruct the endpoint to process the object in a micro-VM as soon as suspicion of the object as malware exceeds a pre-determined threshold.
When processing the traffic, the analysis engine 540 may employ the EP logic 560 to invoke appropriate instrumentation logic 360A of VM 1 to enable communication with the endpoints to perform dynamic analysis and/or correlation of the suspicious object. In an embodiment, correlation (as described herein) may be performed by one or more user mode processes embodied as a correlation engine 570. The instrumentation logic 360A may be configured to monitor different types of objects, such as payloads of network (web) and email packets, although alternatively, there could be separate web-based and email-based MDS appliances, each of which may be deployed the same way and configured to perform that same work. The MDS appliance 200M may include a module that communicates with a similar module on the endpoint to perform the requested instrumentation. For example in the case of email objects, the application may be an email reader that analyzes email traffic captured by the appliance (and endpoint).
Operationally, the MDS appliance may receive (i.e., intercept) and store traffic flowing over the network that is destined to the endpoints. The appliance may analyze the traffic and communicate with the endpoints over the network using a messaging protocol that encapsulates an object of interest (e.g., a file of a network packet). Illustratively, the MDS appliance may deploy a network protocol stack, e.g., of the operating system kernel 230 configured to employ a protocol to communicate with the endpoints. For example, the EP logic 560 may notify an endpoint to process the object using a network message having a MAC address of the endpoint (layer 2 connectivity). Alternatively, the message may include an IP address of the endpoint (layer 3 connectivity).
Correlation Between MDS Appliance and Endpoints
The embodiments herein provide a technique for verifying a determination of an exploit or malware in an object at the MDS appliance 200M through correlation of activity, i.e., behaviors, of the object running on endpoints 200E of the network. As noted, the MDS appliance may be illustratively positioned within the network to intercept communication traffic directed to the endpoints coupled to a segment of the network. The object may be included within, e.g., a payload of a packet associated with the communication traffic. The appliance may analyze the object to render a determination that the object is suspicious and may contain the exploit or malware. In response, the MDS appliance 200M may pull from the endpoints (e.g., poll the endpoints to inquire) or receive a push (e.g., messages from the endpoints) as to whether any of the endpoints may have analyzed the suspect object and observed its behaviors. As noted previously, communication between the endpoints and the MDS appliance may occur directly or indirectly via the SIEM appliance that gathers events (e.g., messages) for bidirectional distribution to/from the MDS appliance and the endpoints.
In an embodiment, each endpoint 200E may maintain a history of object behaviors (e.g., in system logger 470) that have been analyzed (i.e., monitored) and observed over a period of time (e.g., minutes or hours). The analyzed object behaviors (behavior information) may include inferences of the object as a type of exploit or malware, as well as evaluations of states of the object leading to a determination of the exploit or malware. The MDS appliance 200M may poll the endpoints for their histories of behavior information associated with the suspect object. Alternatively, the appliance may receive one or more messages from a group of endpoints about their histories of behavior information associated with the suspect object. If the object's behaviors were analyzed and observed, the endpoints may provide the behavior information to the appliance, which may then invoke the correlation engine 570 to correlate that information, e.g., against correlation rules, to verify its determination of the exploit or malware. In addition, the appliance may task the endpoints to analyze the object, e.g., during run time, to determine whether it contains the exploit and provide the results to the appliance for correlation. Accordingly, the MDS appliance may verify its determination of an exploit within the object by correlating with the endpoints. Notably, SIEM appliance may correlate with the endpoints and communicate with the MDS so as to verify its determination of an exploit within the object.
Advantageously, maintaining a history of object behaviors enables verification (or validation) of states of the activity, e.g., of an object, that has been observed in the past. For example, assume that the micro-hypervisor and micro-VM allow an exploit or malware (within an object) to execute and analyze the object to observe that it has manifested certain states, e.g., creation of one or more files. The exploit or malware may thus be validated and observed using a generated signature of the exploit or malware. Upon obtaining sufficient information or completing the analysis, resources used to process the object at the micro-VM may be reallocated because there may be other objects, such as files of packets that need analysis. Details of the states and behavior of the objects (files) may be recorded in the system logger 470 to thereby maintain a robust identifier and/or signature for the exploit or malware (object), as well as obtain improved forensic information.
In an embodiment, the MDS appliance 200M may poll a selected group of endpoints 200E in order to collect additional behavior information of the suspect object and correlate that information against a set of correction rules of the correlation engine 570 to provide a high level view of the exploit and any potential spreading of the exploit or malware (e.g., as an infection) in the network over the period of time. In another embodiment, the appliance may receive one or more messages from a group of endpoints about the additional behavior information of the suspect object. Such correlation may not be performed at a single endpoint because the views (histories) from many endpoints may be needed to detect a particular type of exploit as it progresses through various stages of behaviors. The high level view of the potential infection from the perspective of multiple endpoints may be needed to detect whether the object contains an exploit or malware. The set of correlation rules employed by the correlation engine 570 to correlate the behavior information collected from the endpoints may be enhanced to identify a pattern of object activity, e.g., a multi-phase attack, throughout the network. Often, an endpoint may experience only part of the multi-phased network attack by an object among many endpoints. For example, an exploit may exhibit delayed activation where one endpoint did not observe any manifestations of the attack by the object, while another endpoint may observe anomalous (malicious) behaviors of the exploit during analysis of the object. By collecting additional behavior information from multiple endpoints, the appliance 200M may be provided with a large sampling of sophisticated object activity with which to correlate and obtain a more complete view of the activity pattern. In response to correlation of the behavior information, the appliance may then task one or more endpoints 200E to monitor (instrument) the suspect object to acquire further behavior information for correlation and determination of the exploit.
The high level view of the exploit and its sophisticated activity and behaviors when running on the endpoints may advantageously enable the appliance 200M to more accurately verify the exploit, e.g., as malware. As noted, correlation of behavior information of the object from many endpoints provides the appliance with more knowledge of the exploit and its potential to execute malware. The additional knowledge may lead the appliance to task those endpoints to provide even more information relating to specific events associated with the behavior of the object. Since an endpoint only has a “local” view of the object's behavior, the appliance may task the endpoints to monitor events and notify the appliance as to the observed behavior in response to those events.
As described herein, the micro-hypervisor 300 may be employed to detect unexpected behavior (or actions) by one or more operating system processes (e.g., application and/or object) executing in the operating system kernel 230 of the MDS appliance 200M or endpoint 200E. The unexpected behavior of the process may be further tracked as suspicious. In response to a task, the micro-hypervisor 300 (via VMM 0 and a spawned micro-VM) of the endpoint may report to the MDS appliance that it has detected and identified an exploit or malware. Unlike VMM 0 which spawns the micro-VM as a container for light-weight (i.e., limited so to maintain user experience) analysis of the process, the MDS appliance 200M includes full virtualized hardware via the hypervisor (VMM 1) that spawns a full (i.e., virtualizing all kernel resources) VM used to analyze the behavior of the operating system process executing on the endpoint. That is, the MDS appliance 200M may be employed to provide more extensive instrumentation than can be provided by VMM 0 and its micro-VM of the endpoint.
In an embodiment, each VM of the appliance may include instrumentation logic (e.g., instrumentation logic 360A-N) having an instrumentation package that includes monitors although, in an alternative embodiment, the instrumentation package may be part of VMM 1. In terms of implementation, different types of instrumentation can attach to the VM. The VM may also be able to dynamically switch between different types of instrumentation at the appliance. Assume a particular type of instrumentation is executing that is relevant to a particular analysis. Subsequently, it may be determined that the instrumentation is not relevant and that some other instrumentation is desired, so the state of the analysis may continue but with a different type of instrumentation. Illustratively, a monitor is a type of instrumentation that monitors the behavior of software code at the micro-hypervisor level.
In an embodiment, the MDS appliance 200M may be located at a periphery of the network, e.g., private network 130, or sub-network (segment) of the network. The location of the appliance may hinder its visibility to peer-to-peer communication traffic among the endpoints 200E. The lack of visibility may lead to spreading of the exploit (infection) among the endpoints where an initial infection at one endpoint may propagate among the other communicating endpoints. The initial infection may penetrate the network to one or more endpoints if it is not detected using, e.g., anti-virus (AV) signatures (indicators), exploit indicators and/or other behavioral indicators at the appliance. Once the infection penetrates the network (e.g., past the peripheral-based appliance 200M) the exploit may disrupt operation of the network. The verification technique described herein may obviate (prevent) any lateral propagation of the infection among the endpoints by enhancing the visibility of the exploit (e.g., its activity when running in the object) at the appliance 200M.
For example, upon verifying the exploit or malware in the object, the appliance may instruct the endpoints to terminate execution of the object and/or an associated operating system process containing the exploit. In response, the micro-hypervisor 300 of each endpoint may prevent lateral propagation of the infection by, e.g., closing network ports and terminating communication with other endpoints and appliances in the private network 130, and/or reporting an alert to an administrator (management) station of the network. Illustratively, the micro-hypervisor 300 may close network ports of the network interfaces 214 (kernel resources) by, e.g., closing any active programs using the ports to thereby terminate communication (i.e., the exchange of information) external to the endpoint. Alternatively, the management station may command the endpoint (via the micro-hypervisor) to terminate external communication in response to the alert (and until the endpoint is “cleansed”). The micro-hypervisor 300 may terminate such communication because of its fine-grained control over the kernel resources. For instance, the micro-hypervisor may terminate a malignant operating system process (or object) by, e.g., removing the process and its associated process control block from a process table.
The MDS appliance 200M may seek further verification of the determination of the infection by tasking one or more selected endpoints 200E running a type of potentially vulnerable software or having characteristics that may otherwise render the endpoints interesting to perform monitoring of the object. For example, an endpoint may be more isolated than other endpoints in the network so an infection may not spread as quickly, if at all. Alternatively, the endpoint may be located in a department of the private network or enterprise (e.g., a financial department) where advanced persistent threats (APTS) may be more prone to access sensitive information (e.g., a financial database). The MDS appliance 200M may instruct the endpoints to monitor the object to detect and observe the exploit (or malware) as it runs (manifests) at the endpoints and then control (e.g., terminate) the infection to prevent lateral spreading among endpoints in the network.
In an embodiment, intelligence may be imparted into the selection of endpoints 200E for verification, wherein the intelligence may include different software profiles such as different types of operating systems (with certain service packs) and/or different types of application programs executing on the endpoints that an exploit or malware of an object may be known to attack. In addition, such intelligence may determine whether identified exploit or malware may attack more than one type of vulnerability in an application executing the object on the endpoints. Certain exploit or malware may target certain software, particularly software with known vulnerabilities to a malware developer. The vulnerability may denote that the software (or feature of the software) is susceptible to attack; as a result, the feature may become a vulnerability. To that end, an inventory of endpoint configurations (software and hardware) including a database of associated vulnerabilities may be provided at the appliance. The appliance may poll (or receive messages) among endpoints with such different software profiles to provide behavior information of the object. The polled information (or messages received) from the endpoints may be correlated by the appliance against the inventory/database to essentially provide a distributed malware detection system. In response, tasks may be assigned to the endpoints to obtain further information that enables enhanced verification of the infection at the appliance. The endpoints 200E may be selected based on software profiles that are conducive to detection of particular malware, which result in behaviors that may be easier to detect/observe.
While there have been shown and described illustrative embodiments for verifying a determination of an exploit or malware in an object at a MDS appliance through correlation of behavior activity of the object running on endpoints of a network, it is to be understood that various other adaptations and modifications may be made within the spirit and scope of the embodiments herein. For example, embodiments have been shown and described herein with relation to the appliance intercepting communication traffic containing the object for which the appliance rendered a determination of suspiciousness. However, the embodiments in their broader sense are not so limited, and may, in fact, provide a centralized database/repository configured to store and enable access to the object (e.g., one or more packets) present in the network during a specified time period.
The foregoing description has been directed to specific embodiments. It will be apparent, however, that other variations and modifications may be made to the described embodiments, with the attainment of some or all of their advantages. For instance, it is expressly contemplated that the components and/or elements described herein can be implemented as software encoded on a tangible (non-transitory) computer-readable medium (e.g., disks, electronic memory, and/or CDs) having program instructions executing on a computer, hardware, firmware, or a combination thereof. Moreover, the embodiments or aspects thereof can be implemented in hardware, firmware, software, or a combination thereof. In the foregoing description, for example, in certain situations, terms such as “engine,” “component” and “logic” are representative of hardware, firmware and/or software that is configured to perform one or more functions. As hardware, engine (or component/logic) may include circuitry having data processing or storage functionality. Examples of such circuitry may include, but is not limited or restricted to a microprocessor, one or more processor cores, a programmable gate array, a microcontroller, an application specific integrated circuit, semiconductor memory, or combinatorial logic. Accordingly this description is to be taken only by way of example and not to otherwise limit the scope of the embodiments herein. Therefore, it is the object of the appended claims to cover all such variations and modifications as come within the true spirit and scope of the embodiments herein.
The present application is a continuation of U.S. patent Ser. No. 15/258,656 filed Sep. 7, 2016, now U.S. Pat. No. 10,826,933, which claims the benefit of priority on U.S. Provisional Patent Application No. 62/316,427, entitled TECHNIQUE FOR VERIFYING EXPLOIT/MALWARE AT MALWARE DETECTION APPLIANCE THROUGH CORRELATION WITH ENDPOINTS, filed on Mar. 31, 2016, and from commonly owned U.S. Provisional Patent Application No. 62/316,390, entitled MALWARE DETECTION VERIFICATION AND ENHANCEMENT USING DETECTION SYSTEMS LOCATED AT THE NETWORK PERIPHERY AND ENDPOINT DEVICES, filed on Mar. 31, 2016 the contents of which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
4292580 | Ott et al. | Sep 1981 | A |
5175732 | Hendel et al. | Dec 1992 | A |
5319776 | Hile et al. | Jun 1994 | A |
5440723 | Arnold et al. | Aug 1995 | A |
5490249 | Miller | Feb 1996 | A |
5657473 | Killean et al. | Aug 1997 | A |
5802277 | Cowlard | Sep 1998 | A |
5842002 | Schnurer et al. | Nov 1998 | A |
5960170 | Chen et al. | Sep 1999 | A |
5978917 | Chi | Nov 1999 | A |
5983348 | Ji | Nov 1999 | A |
6088803 | Tso et al. | Jul 2000 | A |
6092194 | Touboul | Jul 2000 | A |
6094677 | Capek et al. | Jul 2000 | A |
6108799 | Boulay et al. | Aug 2000 | A |
6154844 | Touboul et al. | Nov 2000 | A |
6269330 | Cidon et al. | Jul 2001 | B1 |
6272641 | Ji | Aug 2001 | B1 |
6279113 | Vaidya | Aug 2001 | B1 |
6298445 | Shostack et al. | Oct 2001 | B1 |
6321338 | Porras et al. | Nov 2001 | B1 |
6357008 | Nachenberg | Mar 2002 | B1 |
6424627 | Sørhaug et al. | Jul 2002 | B1 |
6442696 | Wray et al. | Aug 2002 | B1 |
6484315 | Ziese | Nov 2002 | B1 |
6487666 | Shanklin et al. | Nov 2002 | B1 |
6493756 | O'Brien et al. | Dec 2002 | B1 |
6550012 | Villa et al. | Apr 2003 | B1 |
6775657 | Baker | Aug 2004 | B1 |
6831893 | Ben Nun et al. | Dec 2004 | B1 |
6832367 | Choi et al. | Dec 2004 | B1 |
6895550 | Kanchirayappa et al. | May 2005 | B2 |
6898632 | Gordy et al. | May 2005 | B2 |
6907396 | Muttik et al. | Jun 2005 | B1 |
6941348 | Petry et al. | Sep 2005 | B2 |
6971097 | Wallman | Nov 2005 | B1 |
6978015 | Erickson et al. | Dec 2005 | B1 |
6981279 | Arnold et al. | Dec 2005 | B1 |
7007107 | Ivchenko et al. | Feb 2006 | B1 |
7028179 | Anderson et al. | Apr 2006 | B2 |
7043757 | Hoefelmeyer et al. | May 2006 | B2 |
7058822 | Edery et al. | Jun 2006 | B2 |
7069316 | Gryaznov | Jun 2006 | B1 |
7080407 | Zhao et al. | Jul 2006 | B1 |
7080408 | Pak et al. | Jul 2006 | B1 |
7093002 | Wolff et al. | Aug 2006 | B2 |
7093239 | van der Made | Aug 2006 | B1 |
7096498 | Judge | Aug 2006 | B2 |
7100201 | Izatt | Aug 2006 | B2 |
7107617 | Hursey et al. | Sep 2006 | B2 |
7159149 | Spiegel et al. | Jan 2007 | B2 |
7188367 | Edwards et al. | Mar 2007 | B1 |
7213260 | Judge | May 2007 | B2 |
7231667 | Jordan | Jun 2007 | B2 |
7240364 | Branscomb et al. | Jul 2007 | B1 |
7240368 | Roesch et al. | Jul 2007 | B1 |
7243371 | Kasper et al. | Jul 2007 | B1 |
7249175 | Donaldson | Jul 2007 | B1 |
7287278 | Liang | Oct 2007 | B2 |
7308716 | Danford et al. | Dec 2007 | B2 |
7328453 | Merkle, Jr. et al. | Feb 2008 | B2 |
7346486 | Ivancic et al. | Mar 2008 | B2 |
7356736 | Natvig | Apr 2008 | B2 |
7373666 | Kaler | May 2008 | B2 |
7386888 | Liang et al. | Jun 2008 | B2 |
7392542 | Bucher | Jun 2008 | B2 |
7418729 | Szor | Aug 2008 | B2 |
7428300 | Drew et al. | Sep 2008 | B1 |
7441272 | Durham et al. | Oct 2008 | B2 |
7448084 | Apap et al. | Nov 2008 | B1 |
7458098 | Judge et al. | Nov 2008 | B2 |
7464404 | Carpenter et al. | Dec 2008 | B2 |
7464407 | Nakae et al. | Dec 2008 | B2 |
7467408 | O'Toole, Jr. | Dec 2008 | B1 |
7478428 | Thomlinson | Jan 2009 | B1 |
7480773 | Reed | Jan 2009 | B1 |
7487543 | Arnold et al. | Feb 2009 | B2 |
7496960 | Chen et al. | Feb 2009 | B1 |
7496961 | Zimmer et al. | Feb 2009 | B2 |
7519990 | Xie | Apr 2009 | B1 |
7523493 | Liang et al. | Apr 2009 | B2 |
7530104 | Thrower et al. | May 2009 | B1 |
7540025 | Tzadikario | May 2009 | B2 |
7546638 | Anderson et al. | Jun 2009 | B2 |
7565550 | Liang et al. | Jul 2009 | B2 |
7568233 | Szor et al. | Jul 2009 | B1 |
7584455 | Ball | Sep 2009 | B2 |
7600007 | Lewis | Oct 2009 | B1 |
7603715 | Costa et al. | Oct 2009 | B2 |
7607171 | Marsden et al. | Oct 2009 | B1 |
7639714 | Stolfo et al. | Dec 2009 | B2 |
7644441 | Schmid et al. | Jan 2010 | B2 |
7657419 | van der Made | Feb 2010 | B2 |
7676841 | Sobchuk et al. | Mar 2010 | B2 |
7698548 | Shelest et al. | Apr 2010 | B2 |
7707633 | Danford et al. | Apr 2010 | B2 |
7712136 | Sprosts et al. | May 2010 | B2 |
7730011 | Deninger et al. | Jun 2010 | B1 |
7739740 | Nachenberg et al. | Jun 2010 | B1 |
7779463 | Stolfo et al. | Aug 2010 | B2 |
7784097 | Stolfo et al. | Aug 2010 | B1 |
7832008 | Kraemer | Nov 2010 | B1 |
7836500 | Nason et al. | Nov 2010 | B2 |
7836502 | Zhao et al. | Nov 2010 | B1 |
7849506 | Dansey et al. | Dec 2010 | B1 |
7854007 | Sprosts et al. | Dec 2010 | B2 |
7869073 | Oshima | Jan 2011 | B2 |
7877803 | Enstone et al. | Jan 2011 | B2 |
7904959 | Sidiroglou et al. | Mar 2011 | B2 |
7908660 | Bahl | Mar 2011 | B2 |
7930738 | Petersen | Apr 2011 | B1 |
7937387 | Frazier et al. | May 2011 | B2 |
7937761 | Bennett | May 2011 | B1 |
7949849 | Lowe et al. | May 2011 | B2 |
7996556 | Raghavan et al. | Aug 2011 | B2 |
7996836 | McCorkendale et al. | Aug 2011 | B1 |
7996904 | Chiueh et al. | Aug 2011 | B1 |
7996905 | Arnold et al. | Aug 2011 | B2 |
8006305 | Aziz | Aug 2011 | B2 |
8010667 | Zhang et al. | Aug 2011 | B2 |
8020206 | Hubbard et al. | Sep 2011 | B2 |
8028338 | Schneider et al. | Sep 2011 | B1 |
8042178 | Fisher et al. | Oct 2011 | B1 |
8042184 | Batenin | Oct 2011 | B1 |
8045094 | Teragawa | Oct 2011 | B2 |
8045458 | Alperovitch et al. | Oct 2011 | B2 |
8056136 | Zaitsev | Nov 2011 | B1 |
8069484 | McMillan et al. | Nov 2011 | B2 |
8087086 | Lai et al. | Dec 2011 | B1 |
8095964 | Zhong | Jan 2012 | B1 |
8171553 | Aziz et al. | May 2012 | B2 |
8176049 | Deninger et al. | May 2012 | B2 |
8176480 | Spertus | May 2012 | B1 |
8181247 | Pavlyushchik | May 2012 | B1 |
8201246 | Wu et al. | Jun 2012 | B1 |
8204984 | Aziz et al. | Jun 2012 | B1 |
8214905 | Doukhvalov et al. | Jul 2012 | B1 |
8220055 | Kennedy | Jul 2012 | B1 |
8225288 | Miller et al. | Jul 2012 | B2 |
8225373 | Kraemer | Jul 2012 | B2 |
8233882 | Rogel | Jul 2012 | B2 |
8234640 | Fitzgerald et al. | Jul 2012 | B1 |
8234709 | Viljoen et al. | Jul 2012 | B2 |
8239944 | Nachenberg et al. | Aug 2012 | B1 |
8260914 | Ranjan | Sep 2012 | B1 |
8266091 | Gubin et al. | Sep 2012 | B1 |
8286251 | Eker et al. | Oct 2012 | B2 |
8291499 | Aziz et al. | Oct 2012 | B2 |
8307435 | Mann et al. | Nov 2012 | B1 |
8307443 | Wang et al. | Nov 2012 | B2 |
8312545 | Tuvell et al. | Nov 2012 | B2 |
8321936 | Green et al. | Nov 2012 | B1 |
8321941 | Tuvell et al. | Nov 2012 | B2 |
8332571 | Edwards, Sr. | Dec 2012 | B1 |
8365286 | Poston | Jan 2013 | B2 |
8365297 | Parshin et al. | Jan 2013 | B1 |
8370938 | Daswani et al. | Feb 2013 | B1 |
8370939 | Zaitsev et al. | Feb 2013 | B2 |
8375444 | Aziz et al. | Feb 2013 | B2 |
8381299 | Stolfo et al. | Feb 2013 | B2 |
8402529 | Green et al. | Mar 2013 | B1 |
8464340 | Ahn et al. | Jun 2013 | B2 |
8479174 | Chiriac | Jul 2013 | B2 |
8479276 | Vaystikh et al. | Jul 2013 | B1 |
8479291 | Bodke | Jul 2013 | B1 |
8510827 | Leake et al. | Aug 2013 | B1 |
8510828 | Guo et al. | Aug 2013 | B1 |
8510842 | Amit et al. | Aug 2013 | B2 |
8516478 | Edwards et al. | Aug 2013 | B1 |
8516590 | Ranadive et al. | Aug 2013 | B1 |
8516593 | Aziz | Aug 2013 | B2 |
8522348 | Chen et al. | Aug 2013 | B2 |
8528086 | Aziz | Sep 2013 | B1 |
8533824 | Hutton et al. | Sep 2013 | B2 |
8539582 | Aziz et al. | Sep 2013 | B1 |
8549638 | Aziz | Oct 2013 | B2 |
8555388 | Wang et al. | Oct 2013 | B1 |
8555391 | Demir et al. | Oct 2013 | B1 |
8561177 | Aziz et al. | Oct 2013 | B1 |
8566476 | Shiffer et al. | Oct 2013 | B2 |
8566946 | Aziz et al. | Oct 2013 | B1 |
8584094 | Dadhia et al. | Nov 2013 | B2 |
8584234 | Sobel et al. | Nov 2013 | B1 |
8584239 | Aziz et al. | Nov 2013 | B2 |
8595834 | Xie et al. | Nov 2013 | B2 |
8621632 | Smith | Dec 2013 | B1 |
8627476 | Satish et al. | Jan 2014 | B1 |
8635696 | Aziz | Jan 2014 | B1 |
8682054 | Xue et al. | Mar 2014 | B2 |
8682812 | Ranjan | Mar 2014 | B1 |
8689333 | Aziz | Apr 2014 | B2 |
8695096 | Zhang | Apr 2014 | B1 |
8713631 | Pavlyushchik | Apr 2014 | B1 |
8713681 | Silberman et al. | Apr 2014 | B2 |
8726392 | McCorkendale et al. | May 2014 | B1 |
8739280 | Chess et al. | May 2014 | B2 |
8776229 | Aziz | Jul 2014 | B1 |
8782790 | Smith et al. | Jul 2014 | B1 |
8782792 | Bodke | Jul 2014 | B1 |
8789172 | Stolfo et al. | Jul 2014 | B2 |
8789178 | Kejriwal et al. | Jul 2014 | B2 |
8793278 | Frazier et al. | Jul 2014 | B2 |
8793787 | Ismael et al. | Jul 2014 | B2 |
8805947 | Kuzkin et al. | Aug 2014 | B1 |
8806647 | Daswani et al. | Aug 2014 | B1 |
8813222 | Codreanu et al. | Aug 2014 | B1 |
8832829 | Manni et al. | Sep 2014 | B2 |
8850570 | Ramzan | Sep 2014 | B1 |
8850571 | Staniford et al. | Sep 2014 | B2 |
8850584 | Alme et al. | Sep 2014 | B2 |
8854474 | Blumstein-Koren et al. | Oct 2014 | B2 |
8881234 | Narasimhan et al. | Nov 2014 | B2 |
8881271 | Butler, II | Nov 2014 | B2 |
8881282 | Aziz et al. | Nov 2014 | B1 |
8898788 | Aziz et al. | Nov 2014 | B1 |
8935779 | Manni et al. | Jan 2015 | B2 |
8949257 | Shiffer et al. | Feb 2015 | B2 |
8955138 | Mahadik | Feb 2015 | B1 |
8984638 | Aziz et al. | Mar 2015 | B1 |
8990939 | Staniford et al. | Mar 2015 | B2 |
8990944 | Singh et al. | Mar 2015 | B1 |
8997219 | Staniford et al. | Mar 2015 | B2 |
9009822 | Ismael et al. | Apr 2015 | B1 |
9009823 | Ismael et al. | Apr 2015 | B1 |
9027135 | Aziz | May 2015 | B1 |
9071638 | Aziz et al. | Jun 2015 | B1 |
9092616 | Kumar et al. | Jul 2015 | B2 |
9094443 | Martini et al. | Jul 2015 | B1 |
9104867 | Thioux et al. | Aug 2015 | B1 |
9106630 | Frazier et al. | Aug 2015 | B2 |
9106694 | Aziz et al. | Aug 2015 | B2 |
9118715 | Staniford et al. | Aug 2015 | B2 |
9148441 | Tamersoy et al. | Sep 2015 | B1 |
9159035 | Ismael et al. | Oct 2015 | B1 |
9166997 | Guo et al. | Oct 2015 | B1 |
9171154 | Pereira | Oct 2015 | B2 |
9171160 | Vincent et al. | Oct 2015 | B2 |
9176843 | Ismael et al. | Nov 2015 | B1 |
9189627 | Islam | Nov 2015 | B1 |
9195829 | Goradia et al. | Nov 2015 | B1 |
9197664 | Aziz et al. | Nov 2015 | B1 |
9202050 | Nachenberg | Dec 2015 | B1 |
9203862 | Kashyap et al. | Dec 2015 | B1 |
9223972 | Vincent et al. | Dec 2015 | B1 |
9225740 | Ismael et al. | Dec 2015 | B1 |
9241010 | Bennett et al. | Jan 2016 | B1 |
9251343 | Vincent et al. | Feb 2016 | B1 |
9262635 | Paithane et al. | Feb 2016 | B2 |
9268936 | Butler | Feb 2016 | B2 |
9275229 | LeMasters | Mar 2016 | B2 |
9280663 | Pak et al. | Mar 2016 | B2 |
9282109 | Aziz et al. | Mar 2016 | B1 |
9282116 | Rovniaguin | Mar 2016 | B1 |
9292686 | Ismael et al. | Mar 2016 | B2 |
9294501 | Mesdaq et al. | Mar 2016 | B2 |
9300686 | Pidathala et al. | Mar 2016 | B2 |
9306960 | Aziz | Apr 2016 | B1 |
9306974 | Aziz et al. | Apr 2016 | B1 |
9311479 | Manni et al. | Apr 2016 | B1 |
9332029 | Tikhonov | May 2016 | B1 |
9336385 | Spencer | May 2016 | B1 |
9355247 | Thioux et al. | May 2016 | B1 |
9356944 | Aziz | May 2016 | B1 |
9363280 | Rivlin et al. | Jun 2016 | B1 |
9367681 | Ismael et al. | Jun 2016 | B1 |
9398028 | Karandikar et al. | Jul 2016 | B1 |
9401142 | Rothwell et al. | Jul 2016 | B1 |
9413781 | Cunningham et al. | Aug 2016 | B2 |
9426071 | Caldejon et al. | Aug 2016 | B1 |
9430646 | Mushtaq et al. | Aug 2016 | B1 |
9432389 | Khalid et al. | Aug 2016 | B1 |
9438613 | Paithane et al. | Sep 2016 | B1 |
9438622 | Staniford et al. | Sep 2016 | B1 |
9438623 | Thioux et al. | Sep 2016 | B1 |
9459901 | Jung et al. | Oct 2016 | B2 |
9467460 | Otvagin et al. | Oct 2016 | B1 |
9483644 | Paithane et al. | Nov 2016 | B1 |
9495180 | Ismael | Nov 2016 | B2 |
9497213 | Thompson et al. | Nov 2016 | B2 |
9507935 | Ismael et al. | Nov 2016 | B2 |
9516057 | Aziz | Dec 2016 | B2 |
9519782 | Aziz et al. | Dec 2016 | B2 |
9536091 | Paithane et al. | Jan 2017 | B2 |
9537972 | Edwards et al. | Jan 2017 | B1 |
9560059 | Islam | Jan 2017 | B1 |
9565202 | Kindlund et al. | Feb 2017 | B1 |
9578064 | Lango et al. | Feb 2017 | B2 |
9591015 | Amin et al. | Mar 2017 | B1 |
9591020 | Aziz | Mar 2017 | B1 |
9594904 | Jain et al. | Mar 2017 | B1 |
9594905 | Ismael et al. | Mar 2017 | B1 |
9594912 | Thioux et al. | Mar 2017 | B1 |
9609007 | Rivlin et al. | Mar 2017 | B1 |
9626509 | Khalid et al. | Apr 2017 | B1 |
9628498 | Aziz et al. | Apr 2017 | B1 |
9628507 | Haq et al. | Apr 2017 | B2 |
9633134 | Ross | Apr 2017 | B2 |
9635039 | Islam et al. | Apr 2017 | B1 |
9635041 | Warman et al. | Apr 2017 | B1 |
9641544 | Treat et al. | May 2017 | B1 |
9641546 | Manni et al. | May 2017 | B1 |
9654485 | Neumann | May 2017 | B1 |
9661009 | Karandikar et al. | May 2017 | B1 |
9661018 | Aziz | May 2017 | B1 |
9674210 | Oprea et al. | Jun 2017 | B1 |
9674298 | Edwards et al. | Jun 2017 | B1 |
9680862 | Ismael et al. | Jun 2017 | B2 |
9690606 | Ha et al. | Jun 2017 | B1 |
9690933 | Singh et al. | Jun 2017 | B1 |
9690935 | Shiffer et al. | Jun 2017 | B2 |
9690936 | Malik et al. | Jun 2017 | B1 |
9734138 | Rothwell et al. | Aug 2017 | B2 |
9736179 | Ismael | Aug 2017 | B2 |
9740857 | Ismael et al. | Aug 2017 | B2 |
9747446 | Pidathala et al. | Aug 2017 | B1 |
9749294 | Marquardt et al. | Aug 2017 | B1 |
9756074 | Aziz et al. | Sep 2017 | B2 |
9773112 | Rathor et al. | Sep 2017 | B1 |
9781144 | Otvagin et al. | Oct 2017 | B1 |
9787700 | Amin et al. | Oct 2017 | B1 |
9787706 | Otvagin et al. | Oct 2017 | B1 |
9792196 | Ismael et al. | Oct 2017 | B1 |
9824209 | Ismael et al. | Nov 2017 | B1 |
9824211 | Wilson | Nov 2017 | B2 |
9824216 | Khalid et al. | Nov 2017 | B1 |
9825976 | Gomez et al. | Nov 2017 | B1 |
9825989 | Mehra et al. | Nov 2017 | B1 |
9838405 | Guo et al. | Dec 2017 | B1 |
9838408 | Karandikar et al. | Dec 2017 | B1 |
9838411 | Aziz | Dec 2017 | B1 |
9838416 | Aziz | Dec 2017 | B1 |
9838417 | Khalid et al. | Dec 2017 | B1 |
9846776 | Paithane et al. | Dec 2017 | B1 |
9876701 | Caldejon et al. | Jan 2018 | B1 |
9888016 | Amin et al. | Feb 2018 | B1 |
9888019 | Pidathala et al. | Feb 2018 | B1 |
9910988 | Vincent et al. | Mar 2018 | B1 |
9912644 | Cunningham | Mar 2018 | B2 |
9912681 | Ismael et al. | Mar 2018 | B1 |
9912684 | Aziz et al. | Mar 2018 | B1 |
9912691 | Mesdaq et al. | Mar 2018 | B2 |
9912698 | Thioux et al. | Mar 2018 | B1 |
9916440 | Paithane et al. | Mar 2018 | B1 |
9921978 | Chan et al. | Mar 2018 | B1 |
9934376 | Ismael | Apr 2018 | B1 |
9934381 | Kindlund et al. | Apr 2018 | B1 |
9946568 | Ismael et al. | Apr 2018 | B1 |
9954890 | Staniford et al. | Apr 2018 | B1 |
9960975 | Van Horenbeeck | May 2018 | B1 |
9973531 | Thioux | May 2018 | B1 |
9977895 | Danahy | May 2018 | B2 |
10002252 | Ismael et al. | Jun 2018 | B2 |
10019338 | Goradia et al. | Jul 2018 | B1 |
10019573 | Silberman et al. | Jul 2018 | B2 |
10025691 | Ismael et al. | Jul 2018 | B1 |
10025927 | Khalid et al. | Jul 2018 | B1 |
10027689 | Rathor et al. | Jul 2018 | B1 |
10027690 | Aziz et al. | Jul 2018 | B2 |
10027696 | Rivlin et al. | Jul 2018 | B1 |
10033747 | Paithane et al. | Jul 2018 | B1 |
10033748 | Cunningham et al. | Jul 2018 | B1 |
10033753 | Islam et al. | Jul 2018 | B1 |
10033759 | Kabra et al. | Jul 2018 | B1 |
10050998 | Singh | Aug 2018 | B1 |
10068091 | Aziz et al. | Sep 2018 | B1 |
10075455 | Zafar et al. | Sep 2018 | B2 |
10083302 | Paithane et al. | Sep 2018 | B1 |
10084813 | Eyada | Sep 2018 | B2 |
10089461 | Ha et al. | Oct 2018 | B1 |
10097573 | Aziz | Oct 2018 | B1 |
10104102 | Neumann | Oct 2018 | B1 |
10108446 | Steinberg et al. | Oct 2018 | B1 |
10121000 | Rivlin et al. | Nov 2018 | B1 |
10122746 | Manni et al. | Nov 2018 | B1 |
10133863 | Bu et al. | Nov 2018 | B2 |
10133866 | Kumar et al. | Nov 2018 | B1 |
10146810 | Shiffer et al. | Dec 2018 | B2 |
10148693 | Singh et al. | Dec 2018 | B2 |
10165000 | Aziz et al. | Dec 2018 | B1 |
10169585 | Pilipenko et al. | Jan 2019 | B1 |
10176321 | Abbasi et al. | Jan 2019 | B2 |
10178119 | Brandwine et al. | Jan 2019 | B1 |
10181029 | Ismael et al. | Jan 2019 | B1 |
10191861 | Steinberg et al. | Jan 2019 | B1 |
10192052 | Singh et al. | Jan 2019 | B1 |
10198574 | Thioux et al. | Feb 2019 | B1 |
10200384 | Mushtaq et al. | Feb 2019 | B1 |
10200866 | Cratsenburg et al. | Feb 2019 | B1 |
10210329 | Malik et al. | Feb 2019 | B1 |
10216927 | Steinberg | Feb 2019 | B1 |
10218740 | Mesdaq et al. | Feb 2019 | B1 |
10242185 | Goradia | Mar 2019 | B1 |
10333962 | Brandwine et al. | Jun 2019 | B1 |
10454950 | Aziz | Oct 2019 | B1 |
10642753 | Steinberg | May 2020 | B1 |
10650142 | Chen | May 2020 | B1 |
10826933 | Ismael | Nov 2020 | B1 |
10972488 | Pal | Apr 2021 | B2 |
11182476 | Mitelman | Nov 2021 | B2 |
11269977 | Turgeman | Mar 2022 | B2 |
20010005889 | Albrecht | Jun 2001 | A1 |
20010047326 | Broadbent et al. | Nov 2001 | A1 |
20020018903 | Kokubo et al. | Feb 2002 | A1 |
20020038430 | Edwards et al. | Mar 2002 | A1 |
20020091819 | Melchione et al. | Jul 2002 | A1 |
20020095607 | Lin-Hendel | Jul 2002 | A1 |
20020116627 | Tarbotton et al. | Aug 2002 | A1 |
20020144156 | Copeland | Oct 2002 | A1 |
20020162015 | Tang | Oct 2002 | A1 |
20020166063 | Lachman et al. | Nov 2002 | A1 |
20020169952 | DiSanto et al. | Nov 2002 | A1 |
20020184528 | Shevenell et al. | Dec 2002 | A1 |
20020188887 | Largman et al. | Dec 2002 | A1 |
20020194489 | Almogy et al. | Dec 2002 | A1 |
20020194490 | Halperin et al. | Dec 2002 | A1 |
20030021728 | Sharpe et al. | Jan 2003 | A1 |
20030074578 | Ford et al. | Apr 2003 | A1 |
20030084318 | Schertz | May 2003 | A1 |
20030101381 | Mateev et al. | May 2003 | A1 |
20030115483 | Liang | Jun 2003 | A1 |
20030188190 | Aaron et al. | Oct 2003 | A1 |
20030191957 | Hypponen et al. | Oct 2003 | A1 |
20030200460 | Morota et al. | Oct 2003 | A1 |
20030212902 | van der Made | Nov 2003 | A1 |
20030229801 | Kouznetsov et al. | Dec 2003 | A1 |
20030237000 | Denton et al. | Dec 2003 | A1 |
20040003323 | Bennett et al. | Jan 2004 | A1 |
20040006473 | Mills et al. | Jan 2004 | A1 |
20040015712 | Szor | Jan 2004 | A1 |
20040016437 | Cobb | Jan 2004 | A1 |
20040019832 | Arnold et al. | Jan 2004 | A1 |
20040024767 | Chen | Feb 2004 | A1 |
20040047356 | Bauer | Mar 2004 | A1 |
20040083408 | Spiegel et al. | Apr 2004 | A1 |
20040088581 | Brawn et al. | May 2004 | A1 |
20040093513 | Cantrell et al. | May 2004 | A1 |
20040111531 | Staniford et al. | Jun 2004 | A1 |
20040117478 | Triulzi et al. | Jun 2004 | A1 |
20040117624 | Brandt et al. | Jun 2004 | A1 |
20040128355 | Chao et al. | Jul 2004 | A1 |
20040133672 | Bhattacharya et al. | Jul 2004 | A1 |
20040165588 | Pandya | Aug 2004 | A1 |
20040193923 | Hammond, II | Sep 2004 | A1 |
20040236963 | Danford et al. | Nov 2004 | A1 |
20040243349 | Greifeneder et al. | Dec 2004 | A1 |
20040249911 | Alkhatib et al. | Dec 2004 | A1 |
20040255161 | Cavanaugh | Dec 2004 | A1 |
20040268147 | Wiederin et al. | Dec 2004 | A1 |
20050005159 | Oliphant | Jan 2005 | A1 |
20050021740 | Bar et al. | Jan 2005 | A1 |
20050033960 | Vialen et al. | Feb 2005 | A1 |
20050033989 | Poletto et al. | Feb 2005 | A1 |
20050050148 | Mohammadioun et al. | Mar 2005 | A1 |
20050060562 | Bhattacharya et al. | Mar 2005 | A1 |
20050086523 | Zimmer et al. | Apr 2005 | A1 |
20050091513 | Mitomo et al. | Apr 2005 | A1 |
20050091533 | Omote et al. | Apr 2005 | A1 |
20050091652 | Ross et al. | Apr 2005 | A1 |
20050108562 | Khazan et al. | May 2005 | A1 |
20050114663 | Cornell et al. | May 2005 | A1 |
20050125195 | Brendel | Jun 2005 | A1 |
20050149726 | Joshi et al. | Jul 2005 | A1 |
20050157662 | Bingham et al. | Jul 2005 | A1 |
20050183143 | Anderholm et al. | Aug 2005 | A1 |
20050201297 | Peikari | Sep 2005 | A1 |
20050210533 | Copeland et al. | Sep 2005 | A1 |
20050238005 | Chen et al. | Oct 2005 | A1 |
20050240781 | Gassoway | Oct 2005 | A1 |
20050262562 | Gassoway | Nov 2005 | A1 |
20050265331 | Stolfo | Dec 2005 | A1 |
20050283839 | Cowburn | Dec 2005 | A1 |
20060010495 | Cohen et al. | Jan 2006 | A1 |
20060015416 | Hoffman et al. | Jan 2006 | A1 |
20060015715 | Anderson | Jan 2006 | A1 |
20060015747 | Van de Ven | Jan 2006 | A1 |
20060021029 | Brickell et al. | Jan 2006 | A1 |
20060021054 | Costa et al. | Jan 2006 | A1 |
20060031476 | Mathes et al. | Feb 2006 | A1 |
20060047665 | Neil | Mar 2006 | A1 |
20060070130 | Costea et al. | Mar 2006 | A1 |
20060075496 | Carpenter et al. | Apr 2006 | A1 |
20060095968 | Portolani et al. | May 2006 | A1 |
20060101264 | Costea et al. | May 2006 | A1 |
20060101282 | Costea et al. | May 2006 | A1 |
20060101516 | Sudaharan et al. | May 2006 | A1 |
20060101517 | Banzhof et al. | May 2006 | A1 |
20060117385 | Mester et al. | Jun 2006 | A1 |
20060123477 | Raghavan et al. | Jun 2006 | A1 |
20060137012 | Aaron | Jun 2006 | A1 |
20060143709 | Brooks et al. | Jun 2006 | A1 |
20060150249 | Gassen et al. | Jul 2006 | A1 |
20060156380 | Gladstone et al. | Jul 2006 | A1 |
20060161983 | Cothrell et al. | Jul 2006 | A1 |
20060161987 | Levy-Yurista | Jul 2006 | A1 |
20060161989 | Reshef et al. | Jul 2006 | A1 |
20060164199 | Gilde et al. | Jul 2006 | A1 |
20060173992 | Weber et al. | Aug 2006 | A1 |
20060179147 | Tran et al. | Aug 2006 | A1 |
20060184632 | Marino et al. | Aug 2006 | A1 |
20060191010 | Benjamin | Aug 2006 | A1 |
20060221956 | Narayan et al. | Oct 2006 | A1 |
20060236393 | Kramer et al. | Oct 2006 | A1 |
20060242709 | Seinfeld et al. | Oct 2006 | A1 |
20060248519 | Jaeger et al. | Nov 2006 | A1 |
20060248582 | Panjwani et al. | Nov 2006 | A1 |
20060251104 | Koga | Nov 2006 | A1 |
20060288417 | Bookbinder et al. | Dec 2006 | A1 |
20070006288 | Mayfield et al. | Jan 2007 | A1 |
20070006313 | Porras et al. | Jan 2007 | A1 |
20070008098 | Wong | Jan 2007 | A1 |
20070011174 | Takaragi et al. | Jan 2007 | A1 |
20070016951 | Piccard et al. | Jan 2007 | A1 |
20070019286 | Kikuchi | Jan 2007 | A1 |
20070033645 | Jones | Feb 2007 | A1 |
20070038677 | Reasor et al. | Feb 2007 | A1 |
20070038943 | FitzGerald et al. | Feb 2007 | A1 |
20070064689 | Shin et al. | Mar 2007 | A1 |
20070074169 | Chess et al. | Mar 2007 | A1 |
20070089165 | Wei et al. | Apr 2007 | A1 |
20070094730 | Bhikkaji et al. | Apr 2007 | A1 |
20070101435 | Konanka et al. | May 2007 | A1 |
20070121596 | Kurapati et al. | May 2007 | A1 |
20070128855 | Cho et al. | Jun 2007 | A1 |
20070130319 | Tse et al. | Jun 2007 | A1 |
20070142030 | Sinha et al. | Jun 2007 | A1 |
20070143827 | Nicodemus et al. | Jun 2007 | A1 |
20070156895 | Vuong | Jul 2007 | A1 |
20070157180 | Tillmann et al. | Jul 2007 | A1 |
20070157306 | Elrod et al. | Jul 2007 | A1 |
20070168988 | Eisner et al. | Jul 2007 | A1 |
20070171824 | Ruello et al. | Jul 2007 | A1 |
20070174915 | Gribble et al. | Jul 2007 | A1 |
20070192500 | Lum | Aug 2007 | A1 |
20070192858 | Lum | Aug 2007 | A1 |
20070192866 | Sagoo | Aug 2007 | A1 |
20070198275 | Malden et al. | Aug 2007 | A1 |
20070208822 | Wang et al. | Sep 2007 | A1 |
20070209074 | Coffman | Sep 2007 | A1 |
20070220607 | Sprosts et al. | Sep 2007 | A1 |
20070240218 | Tuvell et al. | Oct 2007 | A1 |
20070240219 | Tuvell et al. | Oct 2007 | A1 |
20070240220 | Tuvell et al. | Oct 2007 | A1 |
20070240222 | Tuvell et al. | Oct 2007 | A1 |
20070250930 | Aziz et al. | Oct 2007 | A1 |
20070256127 | Kraemer et al. | Nov 2007 | A1 |
20070256132 | Oliphant | Nov 2007 | A2 |
20070271446 | Nakamura | Nov 2007 | A1 |
20080005782 | Aziz | Jan 2008 | A1 |
20080005797 | Field | Jan 2008 | A1 |
20080018122 | Zierler et al. | Jan 2008 | A1 |
20080028463 | Dagon et al. | Jan 2008 | A1 |
20080040710 | Chiriac | Feb 2008 | A1 |
20080046781 | Childs et al. | Feb 2008 | A1 |
20080047013 | Claudatos | Feb 2008 | A1 |
20080066179 | Liu | Mar 2008 | A1 |
20080072326 | Danford et al. | Mar 2008 | A1 |
20080077793 | Tan et al. | Mar 2008 | A1 |
20080080518 | Hoeflin et al. | Apr 2008 | A1 |
20080086720 | Lekel | Apr 2008 | A1 |
20080098476 | Syversen | Apr 2008 | A1 |
20080120722 | Sima et al. | May 2008 | A1 |
20080134178 | Fitzgerald et al. | Jun 2008 | A1 |
20080134334 | Kim et al. | Jun 2008 | A1 |
20080141376 | Clausen et al. | Jun 2008 | A1 |
20080184367 | McMillan et al. | Jul 2008 | A1 |
20080184373 | Traut et al. | Jul 2008 | A1 |
20080189787 | Arnold et al. | Aug 2008 | A1 |
20080201778 | Guo et al. | Aug 2008 | A1 |
20080209557 | Herley et al. | Aug 2008 | A1 |
20080215742 | Goldszmidt et al. | Sep 2008 | A1 |
20080222729 | Chen et al. | Sep 2008 | A1 |
20080244742 | Neystadt et al. | Oct 2008 | A1 |
20080263665 | Ma et al. | Oct 2008 | A1 |
20080295172 | Bohacek | Nov 2008 | A1 |
20080301810 | Lehane et al. | Dec 2008 | A1 |
20080307524 | Singh et al. | Dec 2008 | A1 |
20080313738 | Enderby | Dec 2008 | A1 |
20080320594 | Jiang | Dec 2008 | A1 |
20090003317 | Kasralikar et al. | Jan 2009 | A1 |
20090007100 | Field et al. | Jan 2009 | A1 |
20090013408 | Schipka | Jan 2009 | A1 |
20090031423 | Liu et al. | Jan 2009 | A1 |
20090036111 | Danford et al. | Feb 2009 | A1 |
20090037835 | Goldman | Feb 2009 | A1 |
20090044024 | Oberheide et al. | Feb 2009 | A1 |
20090044274 | Budko et al. | Feb 2009 | A1 |
20090064332 | Porras et al. | Mar 2009 | A1 |
20090077666 | Chen et al. | Mar 2009 | A1 |
20090083369 | Marmor | Mar 2009 | A1 |
20090083855 | Apap et al. | Mar 2009 | A1 |
20090089879 | Wang et al. | Apr 2009 | A1 |
20090094697 | Provos et al. | Apr 2009 | A1 |
20090113425 | Ports et al. | Apr 2009 | A1 |
20090125976 | Wassermann et al. | May 2009 | A1 |
20090126015 | Monastyrsky et al. | May 2009 | A1 |
20090126016 | Sobko et al. | May 2009 | A1 |
20090133125 | Choi et al. | May 2009 | A1 |
20090138303 | Seshadri | May 2009 | A1 |
20090144823 | Lamastra et al. | Jun 2009 | A1 |
20090158430 | Borders | Jun 2009 | A1 |
20090172815 | Gu et al. | Jul 2009 | A1 |
20090187992 | Poston | Jul 2009 | A1 |
20090193293 | Stolfo et al. | Jul 2009 | A1 |
20090198651 | Shiffer et al. | Aug 2009 | A1 |
20090198670 | Shiffer et al. | Aug 2009 | A1 |
20090198689 | Frazier et al. | Aug 2009 | A1 |
20090199274 | Frazier et al. | Aug 2009 | A1 |
20090199296 | Xie et al. | Aug 2009 | A1 |
20090228233 | Anderson et al. | Sep 2009 | A1 |
20090241187 | Troyansky | Sep 2009 | A1 |
20090241190 | Todd et al. | Sep 2009 | A1 |
20090265692 | Godefroid et al. | Oct 2009 | A1 |
20090271867 | Zhang | Oct 2009 | A1 |
20090282478 | Jiang | Nov 2009 | A1 |
20090300415 | Zhang et al. | Dec 2009 | A1 |
20090300761 | Park et al. | Dec 2009 | A1 |
20090328185 | Berg et al. | Dec 2009 | A1 |
20090328221 | Blumfield et al. | Dec 2009 | A1 |
20100005146 | Drako et al. | Jan 2010 | A1 |
20100011205 | McKenna | Jan 2010 | A1 |
20100017546 | Poo et al. | Jan 2010 | A1 |
20100030996 | Butler, II | Feb 2010 | A1 |
20100031353 | Thomas et al. | Feb 2010 | A1 |
20100037314 | Perdisci et al. | Feb 2010 | A1 |
20100043073 | Kuwamura | Feb 2010 | A1 |
20100054278 | Stolfo et al. | Mar 2010 | A1 |
20100058474 | Hicks | Mar 2010 | A1 |
20100064044 | Nonoyama | Mar 2010 | A1 |
20100071051 | Choyi et al. | Mar 2010 | A1 |
20100077481 | Polyakov et al. | Mar 2010 | A1 |
20100083376 | Pereira et al. | Apr 2010 | A1 |
20100094459 | Cho et al. | Apr 2010 | A1 |
20100115621 | Staniford et al. | May 2010 | A1 |
20100132038 | Zaitsev | May 2010 | A1 |
20100154056 | Smith et al. | Jun 2010 | A1 |
20100180344 | Malyshev et al. | Jul 2010 | A1 |
20100192223 | Ismael et al. | Jul 2010 | A1 |
20100220863 | Dupaquis et al. | Sep 2010 | A1 |
20100235831 | Dittmer | Sep 2010 | A1 |
20100251104 | Massand | Sep 2010 | A1 |
20100281102 | Chinta et al. | Nov 2010 | A1 |
20100281540 | Alme | Nov 2010 | A1 |
20100281541 | Stolfo et al. | Nov 2010 | A1 |
20100281542 | Stolfo et al. | Nov 2010 | A1 |
20100287260 | Peterson et al. | Nov 2010 | A1 |
20100299754 | Amit et al. | Nov 2010 | A1 |
20100306173 | Frank | Dec 2010 | A1 |
20110004737 | Greenebaum | Jan 2011 | A1 |
20110025504 | Lyon et al. | Feb 2011 | A1 |
20110041179 | St Hlberg | Feb 2011 | A1 |
20110047594 | Mahaffey et al. | Feb 2011 | A1 |
20110047597 | Mahaffey et al. | Feb 2011 | A1 |
20110047620 | Mahaffey et al. | Feb 2011 | A1 |
20110055907 | Narasimhan et al. | Mar 2011 | A1 |
20110055925 | Jakobsson | Mar 2011 | A1 |
20110078794 | Manni et al. | Mar 2011 | A1 |
20110093951 | Aziz | Apr 2011 | A1 |
20110099620 | Stavrou et al. | Apr 2011 | A1 |
20110099633 | Aziz | Apr 2011 | A1 |
20110099635 | Silberman et al. | Apr 2011 | A1 |
20110113231 | Kaminsky | May 2011 | A1 |
20110145918 | Jung et al. | Jun 2011 | A1 |
20110145920 | Mahaffey et al. | Jun 2011 | A1 |
20110145934 | Abramovici et al. | Jun 2011 | A1 |
20110167493 | Song et al. | Jul 2011 | A1 |
20110167494 | Bowen et al. | Jul 2011 | A1 |
20110173213 | Frazier et al. | Jul 2011 | A1 |
20110173460 | Ito et al. | Jul 2011 | A1 |
20110191849 | Jayaraman et al. | Aug 2011 | A1 |
20110219449 | St. Neitzel et al. | Sep 2011 | A1 |
20110219450 | McDougal et al. | Sep 2011 | A1 |
20110225624 | Sawhney et al. | Sep 2011 | A1 |
20110225655 | Niemela et al. | Sep 2011 | A1 |
20110247072 | Staniford et al. | Oct 2011 | A1 |
20110265182 | Peinado et al. | Oct 2011 | A1 |
20110288692 | Scott | Nov 2011 | A1 |
20110289582 | Kejriwal et al. | Nov 2011 | A1 |
20110302587 | Nishikawa et al. | Dec 2011 | A1 |
20110302656 | El-Moussa | Dec 2011 | A1 |
20110307954 | Melnik et al. | Dec 2011 | A1 |
20110307955 | Kaplan et al. | Dec 2011 | A1 |
20110307956 | Yermakov et al. | Dec 2011 | A1 |
20110314546 | Aziz et al. | Dec 2011 | A1 |
20120023593 | Puder et al. | Jan 2012 | A1 |
20120030750 | Bhargava | Feb 2012 | A1 |
20120036576 | Iyer | Feb 2012 | A1 |
20120054869 | Yen et al. | Mar 2012 | A1 |
20120066698 | Yanoo | Mar 2012 | A1 |
20120079596 | Thomas et al. | Mar 2012 | A1 |
20120084859 | Radinsky et al. | Apr 2012 | A1 |
20120096553 | Srivastava et al. | Apr 2012 | A1 |
20120110667 | Zubrilin et al. | May 2012 | A1 |
20120117652 | Manni et al. | May 2012 | A1 |
20120121154 | Xue et al. | May 2012 | A1 |
20120124426 | Maybee et al. | May 2012 | A1 |
20120174186 | Aziz et al. | Jul 2012 | A1 |
20120174196 | Bhogavilli et al. | Jul 2012 | A1 |
20120174218 | McCoy et al. | Jul 2012 | A1 |
20120198279 | Schroeder | Aug 2012 | A1 |
20120210423 | Friedrichs et al. | Aug 2012 | A1 |
20120222121 | Staniford et al. | Aug 2012 | A1 |
20120254995 | Sallam | Oct 2012 | A1 |
20120255001 | Sallam | Oct 2012 | A1 |
20120255003 | Sallam | Oct 2012 | A1 |
20120255004 | Sallam | Oct 2012 | A1 |
20120255012 | Sallam | Oct 2012 | A1 |
20120255013 | Sallam | Oct 2012 | A1 |
20120255015 | Sahita et al. | Oct 2012 | A1 |
20120255017 | Sallam | Oct 2012 | A1 |
20120260342 | Dube et al. | Oct 2012 | A1 |
20120266244 | Green et al. | Oct 2012 | A1 |
20120278886 | Luna | Nov 2012 | A1 |
20120297489 | Dequevy | Nov 2012 | A1 |
20120304244 | Xie et al. | Nov 2012 | A1 |
20120330801 | McDougal et al. | Dec 2012 | A1 |
20120331553 | Aziz et al. | Dec 2012 | A1 |
20130014259 | Gribble et al. | Jan 2013 | A1 |
20130036472 | Aziz | Feb 2013 | A1 |
20130042294 | Colvin et al. | Feb 2013 | A1 |
20130047257 | Aziz | Feb 2013 | A1 |
20130074185 | McDougal et al. | Mar 2013 | A1 |
20130086247 | Burckart et al. | Apr 2013 | A1 |
20130086684 | Mohler | Apr 2013 | A1 |
20130097699 | Balupari et al. | Apr 2013 | A1 |
20130097706 | Titonis et al. | Apr 2013 | A1 |
20130111587 | Goel et al. | May 2013 | A1 |
20130117852 | Stute | May 2013 | A1 |
20130117855 | Kim et al. | May 2013 | A1 |
20130139264 | Brinkley et al. | May 2013 | A1 |
20130145463 | Ghosh et al. | Jun 2013 | A1 |
20130160125 | Likhachev et al. | Jun 2013 | A1 |
20130160127 | Jeong et al. | Jun 2013 | A1 |
20130160130 | Mendelev et al. | Jun 2013 | A1 |
20130160131 | Madou et al. | Jun 2013 | A1 |
20130167236 | Sick | Jun 2013 | A1 |
20130174214 | Duncan | Jul 2013 | A1 |
20130185789 | Hagiwara et al. | Jul 2013 | A1 |
20130185795 | Winn et al. | Jul 2013 | A1 |
20130185798 | Saunders et al. | Jul 2013 | A1 |
20130191915 | Antonakakis et al. | Jul 2013 | A1 |
20130196649 | Paddon et al. | Aug 2013 | A1 |
20130227691 | Aziz et al. | Aug 2013 | A1 |
20130246370 | Bartram et al. | Sep 2013 | A1 |
20130247186 | LeMasters | Sep 2013 | A1 |
20130263260 | Mahaffey et al. | Oct 2013 | A1 |
20130291109 | Staniford et al. | Oct 2013 | A1 |
20130298192 | Kumar | Nov 2013 | A1 |
20130298243 | Kumar et al. | Nov 2013 | A1 |
20130303154 | Gupta | Nov 2013 | A1 |
20130304869 | Gupta | Nov 2013 | A1 |
20130305369 | Karta et al. | Nov 2013 | A1 |
20130318038 | Shiffer et al. | Nov 2013 | A1 |
20130318073 | Shiffer et al. | Nov 2013 | A1 |
20130325791 | Shiffer et al. | Dec 2013 | A1 |
20130325792 | Shiffer et al. | Dec 2013 | A1 |
20130325871 | Shiffer et al. | Dec 2013 | A1 |
20130325872 | Shiffer et al. | Dec 2013 | A1 |
20130340080 | Gostev | Dec 2013 | A1 |
20140007238 | Magee et al. | Jan 2014 | A1 |
20140013434 | Ranum et al. | Jan 2014 | A1 |
20140032875 | Butler | Jan 2014 | A1 |
20140053260 | Gupta | Feb 2014 | A1 |
20140053261 | Gupta et al. | Feb 2014 | A1 |
20140068769 | Neil | Mar 2014 | A1 |
20140130158 | Wang et al. | May 2014 | A1 |
20140130161 | Golovanov | May 2014 | A1 |
20140137180 | Lukacs et al. | May 2014 | A1 |
20140157405 | Joll et al. | Jun 2014 | A1 |
20140169762 | Ryu | Jun 2014 | A1 |
20140179360 | Jackson et al. | Jun 2014 | A1 |
20140181131 | Ross | Jun 2014 | A1 |
20140189687 | Jung et al. | Jul 2014 | A1 |
20140189866 | Shiffer et al. | Jul 2014 | A1 |
20140189882 | Jung et al. | Jul 2014 | A1 |
20140215608 | Rajagopalan et al. | Jul 2014 | A1 |
20140237600 | Silberman et al. | Aug 2014 | A1 |
20140245374 | Deerman et al. | Aug 2014 | A1 |
20140280245 | Wilson | Sep 2014 | A1 |
20140283037 | Sikorski et al. | Sep 2014 | A1 |
20140283063 | Thompson et al. | Sep 2014 | A1 |
20140283066 | Teddy et al. | Sep 2014 | A1 |
20140289323 | Kutaragi et al. | Sep 2014 | A1 |
20140328204 | Klotsche et al. | Nov 2014 | A1 |
20140337836 | Ismael | Nov 2014 | A1 |
20140337862 | Valencia et al. | Nov 2014 | A1 |
20140344926 | Cunningham et al. | Nov 2014 | A1 |
20140351935 | Shao et al. | Nov 2014 | A1 |
20140373155 | Whitehouse et al. | Dec 2014 | A1 |
20140380473 | Bu et al. | Dec 2014 | A1 |
20140380474 | Paithane et al. | Dec 2014 | A1 |
20150007312 | Pidathala et al. | Jan 2015 | A1 |
20150007325 | Eliseev et al. | Jan 2015 | A1 |
20150047046 | Pavlyushchik | Feb 2015 | A1 |
20150067862 | Yu et al. | Mar 2015 | A1 |
20150067866 | Ibatullin et al. | Mar 2015 | A1 |
20150074806 | Roundy et al. | Mar 2015 | A1 |
20150096022 | Vincent et al. | Apr 2015 | A1 |
20150096023 | Mesdaq et al. | Apr 2015 | A1 |
20150096024 | Haq et al. | Apr 2015 | A1 |
20150096025 | Ismael | Apr 2015 | A1 |
20150101047 | Sridhara et al. | Apr 2015 | A1 |
20150101048 | Sridhara et al. | Apr 2015 | A1 |
20150106942 | Borghetti et al. | Apr 2015 | A1 |
20150121524 | Fawaz et al. | Apr 2015 | A1 |
20150150130 | Fiala et al. | May 2015 | A1 |
20150161386 | Gupta et al. | Jun 2015 | A1 |
20150163121 | Mahaffey et al. | Jun 2015 | A1 |
20150180886 | Staniford et al. | Jun 2015 | A1 |
20150186645 | Aziz et al. | Jul 2015 | A1 |
20150199513 | Ismael et al. | Jul 2015 | A1 |
20150199531 | Ismael et al. | Jul 2015 | A1 |
20150199532 | Ismael et al. | Jul 2015 | A1 |
20150205962 | Swidowski et al. | Jul 2015 | A1 |
20150220734 | Nalluri et al. | Aug 2015 | A1 |
20150220735 | Paithane et al. | Aug 2015 | A1 |
20150244730 | Vu et al. | Aug 2015 | A1 |
20150288659 | Lukacs et al. | Oct 2015 | A1 |
20150327518 | Han et al. | Nov 2015 | A1 |
20150365427 | Ben-Shalom et al. | Dec 2015 | A1 |
20150372980 | Eyada | Dec 2015 | A1 |
20160004869 | Ismael et al. | Jan 2016 | A1 |
20160006756 | Ismael et al. | Jan 2016 | A1 |
20160014159 | Schrecker | Jan 2016 | A1 |
20160019388 | Singla et al. | Jan 2016 | A1 |
20160034361 | Block et al. | Feb 2016 | A1 |
20160044000 | Cunningham | Feb 2016 | A1 |
20160065601 | Gong et al. | Mar 2016 | A1 |
20160078225 | Ray et al. | Mar 2016 | A1 |
20160078229 | Gong et al. | Mar 2016 | A1 |
20160078347 | Salajegheh et al. | Mar 2016 | A1 |
20160080345 | Safruti et al. | Mar 2016 | A1 |
20160080413 | Smith et al. | Mar 2016 | A1 |
20160080417 | Thomas et al. | Mar 2016 | A1 |
20160080418 | Ray et al. | Mar 2016 | A1 |
20160080420 | Ray et al. | Mar 2016 | A1 |
20160092682 | Adams | Mar 2016 | A1 |
20160099963 | Mahaffey et al. | Apr 2016 | A1 |
20160112451 | Jevans | Apr 2016 | A1 |
20160127367 | Jevans | May 2016 | A1 |
20160127393 | Aziz et al. | May 2016 | A1 |
20160127406 | Smith et al. | May 2016 | A1 |
20160142432 | Manadhata et al. | May 2016 | A1 |
20160164960 | Marinelli et al. | Jun 2016 | A1 |
20160173509 | Ray et al. | Jun 2016 | A1 |
20160173510 | Harris et al. | Jun 2016 | A1 |
20160191465 | Thomas et al. | Jun 2016 | A1 |
20160191547 | Zafar et al. | Jun 2016 | A1 |
20160191550 | Ismael et al. | Jun 2016 | A1 |
20160205138 | Krishnaprasad | Jul 2016 | A1 |
20160232353 | Gupta et al. | Aug 2016 | A1 |
20160253498 | Valencia et al. | Sep 2016 | A1 |
20160261465 | Gupta | Sep 2016 | A1 |
20160261612 | Mesdaq et al. | Sep 2016 | A1 |
20160285897 | Gantman et al. | Sep 2016 | A1 |
20160285914 | Singh et al. | Sep 2016 | A1 |
20160301703 | Aziz | Oct 2016 | A1 |
20160301704 | Hassanzadeh et al. | Oct 2016 | A1 |
20160301709 | Hassanzadeh et al. | Oct 2016 | A1 |
20160314298 | Martini et al. | Oct 2016 | A1 |
20160323295 | Joram et al. | Nov 2016 | A1 |
20160323304 | Terada | Nov 2016 | A1 |
20160335110 | Paithane et al. | Nov 2016 | A1 |
20160359890 | Deen et al. | Dec 2016 | A1 |
20160379136 | Chen et al. | Dec 2016 | A1 |
20160381057 | Das et al. | Dec 2016 | A1 |
20170017537 | Razin et al. | Jan 2017 | A1 |
20170026949 | Ouyang et al. | Jan 2017 | A1 |
20170046510 | Chen et al. | Feb 2017 | A1 |
20170083703 | Abbasi et al. | Mar 2017 | A1 |
20170083705 | Lee et al. | Mar 2017 | A1 |
20170093899 | Horesh et al. | Mar 2017 | A1 |
20170118241 | Call et al. | Apr 2017 | A1 |
20170149804 | Kolbitsch et al. | May 2017 | A1 |
20170171235 | Mulchandani | Jun 2017 | A1 |
20170195347 | Hay et al. | Jul 2017 | A1 |
20170223046 | Singh | Aug 2017 | A1 |
20170243000 | Shraim et al. | Aug 2017 | A1 |
20170249560 | Cudak et al. | Aug 2017 | A1 |
20170272453 | Murray et al. | Sep 2017 | A1 |
20170316206 | Zou et al. | Nov 2017 | A1 |
20180013770 | Ismael | Jan 2018 | A1 |
20180048660 | Paithane et al. | Feb 2018 | A1 |
20180096142 | Xu et al. | Apr 2018 | A1 |
20180121316 | Ismael et al. | May 2018 | A1 |
20180176247 | Smith et al. | Jun 2018 | A1 |
20180189484 | Danahy | Jul 2018 | A1 |
20180288077 | Siddiqui et al. | Oct 2018 | A1 |
20180322286 | Diehl | Nov 2018 | A1 |
20190081967 | Balabine | Mar 2019 | A1 |
20220038483 | George | Feb 2022 | A1 |
Number | Date | Country |
---|---|---|
2439806 | Jan 2008 | GB |
2490431 | Oct 2012 | GB |
0206928 | Jan 2002 | WO |
0223805 | Mar 2002 | WO |
2007117636 | Oct 2007 | WO |
2008041950 | Apr 2008 | WO |
2011084431 | Jul 2011 | WO |
2011112348 | Sep 2011 | WO |
2012075336 | Jun 2012 | WO |
2012145066 | Oct 2012 | WO |
2013067505 | May 2013 | WO |
Entry |
---|
U.S. Appl. No. 15/258,656, filed Sep. 7, 2016 Advisory Action dated Jan. 31, 2019. |
U.S. Appl. No. 15/258,656, filed Sep. 7, 2016 Final Office Action dated Oct. 26, 2018. |
U.S. Appl. No. 15/258,656, filed Sep. 7, 2016 Final Office Action dated Sep. 18, 2019. |
U.S. Appl. No. 15/258,656, filed Sep. 7, 2016 Non-Final Office Action dated Apr. 6, 2018. |
U.S. Appl. No. 15/258,656, filed Sep. 7, 2016 Non-Final Office Action dated Jan. 31, 2020. |
U.S. Appl. No. 15/258,656, filed Sep. 7, 2016 Non-Final Office Action dated May 30, 2019. |
U.S. Appl. No. 15/258,656, filed Sep. 7, 2016 Notice of Allowance dated May 27, 2020. |
U.S. Appl. No. 15/473,154, filed Mar. 29, 2017 Final Office Action dated Apr. 29, 2019. |
U.S. Appl. No. 15/473,154, filed Mar. 29, 2017 Non-Final Office Action dated Feb. 26, 2020. |
U.S. Appl. No. 15/473,154, filed Mar. 29, 2017 Non-Final Office Action dated Nov. 29, 2018. |
Venezia, Paul , “NetDetector Captures Intrusions”, InfoWorld Issue 27, (“Venezia”), (Jul. 14, 2003). |
Vladimir Getov: “Security as a Service in Smart Clouds—Opportunities and Concerns”, Computer Software and Applications Conference (COMPSAC), 2012 IEEE 36th Annual, IEEE, Jul. 16, 2012 (Jul. 16, 2012). |
Wahid et al., Characterising the Evolution in Scanning Activity of Suspicious Hosts, Oct. 2009, Third International Conference on Network and System Security, pp. 344-350. |
Whyte, et al., “DNS-Based Detection of Scanning Works in an Enterprise Network”, Proceedings of the 12th Annual Network and Distributed System Security Symposium, (Feb. 2005), 15 pages. |
Williamson, Matthew M., “Throttling Viruses: Restricting Propagation to Defeat Malicious Mobile Code”, ACSAC Conference, Las Vegas, NV, USA, (Dec. 2002), pp. 1-9. |
Yuhei Kawakoya et al: “Memory behavior-based automatic malware unpacking in stealth debugging environment”, Malicious and Unwanted Software (Malware), 2010 5th International Conference on, IEEE, Piscataway, NJ, USA, Oct. 19, 2010, pp. 39-46, XP031833827, ISBN:978-1-4244-8-9353-1. |
Zhang et al., The Effects of Threading, Infection Time, and Multiple-Attacker Collaboration on Malware Propagation, Sep. 2009, IEEE 28th International Symposium on Reliable Distributed Systems, pp. 73-82. |
“Mining Specification of Malicious Behavior”—Jha et al, UCSB, Sep. 2007 https://www.cs.ucsb.edu/.about.chris/research/doc/esec07.sub.--mining.pdf-. |
“Network Security: NetDetector—Network Intrusion Forensic System (NIFS) Whitepaper”, (“NetDetector Whitepaper”), (2003). |
“When Virtual is Better Than Real”, IEEEXplore Digital Library, available at, http://ieeexplore.ieee.org/xpl/articleDetails.isp?reload=true&arnumbe- r=990073, (Dec. 7, 2013). |
Abdullah, et al., Visualizing Network Data for Intrusion Detection, 2005 IEEE Workshop on Information Assurance and Security, pp. 100-108. |
Adetoye, Adedayo , et al., “Network Intrusion Detection & Response System”, (“Adetoye”), (Sep. 2003). |
Apostolopoulos, George; hassapis, Constantinos; “V-eM: A cluster of Virtual Machines for Robust, Detailed, and High-Performance Network Emulation”, 14th IEEE International Symposium on Modeling, Analysis, and Simulation of Computer and Telecommunication Systems, Sep. 11-14, 2006, pp. 117-126. |
Aura, Tuomas, “Scanning electronic documents for personally identifiable information”, Proceedings of the 5th ACM workshop on Privacy in electronic society. ACM, 2006. |
Baecher, “The Nepenthes Platform: An Efficient Approach to collect Malware”, Springer-verlag Berlin Heidelberg, (2006), pp. 165-184. |
Bayer, et al., “Dynamic Analysis of Malicious Code”, J Comput Virol, Springer-Verlag, France., (2006), pp. 67-77. |
Boubalos, Chris , “extracting syslog data out of raw pcap dumps, seclists.org, Honeypots mailing list archives”, available at http://seclists.org/honeypots/2003/q2/319 (“Boubalos”), (Jun. 5, 2003). |
Chaudet, C. , et al., “Optimal Positioning of Active and Passive Monitoring Devices”, International Conference on Emerging Networking Experiments and Technologies, Proceedings of the 2005 ACM Conference on Emerging Network Experiment and Technology, CoNEXT '05, Toulousse, France, (Oct. 2005), pp. 71-82. |
Chen, P. M. and Noble, B. D., “When Virtual is Better Than Real, Department of Electrical Engineering and Computer Science”, University of Michigan (“Chen”) (2001). |
Cisco “Intrusion Prevention for the Cisco ASA 5500-x Series” Data Sheet (2012). |
Cohen, M.I. , “PyFlag—An advanced network forensic framework”, Digital investigation 5, Elsevier, (2008), pp. S112-S120. |
Costa, M. , et al., “Vigilante: End-to-End Containment of Internet Worms”, SOSP '05, Association for Computing Machinery, Inc., Brighton U.K., (Oct. 23-26, 2005). |
Didier Stevens, “Malicious PDF Documents Explained”, Security & Privacy, IEEE, IEEE Service Center, Los Alamitos, CA, US, vol. 9, No. 1, Jan. 1, 2011, pp. 80-82, XP011329453, ISSN: 1540-7993, DOI: 10.1109/MSP.2011.14. |
Distler, “Malware Analysis: An Introduction”, SANS Institute InfoSec Reading Room, SANS Institute, (2007). |
Dunlap, George W. , et al., “ReVirt: Enabling Intrusion Analysis through Virtual-Machine Logging and Replay”, Proceeding of the 5th Symposium on Operating Systems Design and Implementation, USENIX Association, (“Dunlap”), (Dec. 9, 2002). |
FireEye Malware Analysis & Exchange Network, Malware Protection System, FireEye Inc., 2010. |
FireEye Malware Analysis, Modern Malware Forensics, FireEye Inc., 2010. |
FireEye v.6.0 Security Target, pp. 1-35, Version 1.1, FireEye Inc., May 2011. |
Goel, et al., Reconstructing System State for Intrusion Analysis, Apr. 2008 SIGOPS Operating Systems Review, vol. 42 Issue 3, pp. 21-28. |
Gregg Keizer: “Microsoft's HoneyMonkeys Show Patching Windows Works”, Aug. 8, 2005, XP055143386, Retrieved from the Internet: URL:http://www.informationweek.com/microsofts-honeymonkeys-show-patching-windows-works/d/d-id/1035069? [retrieved on Jun. 1, 2016]. |
Heng Yin et al, Panorama: Capturing System-Wide Information Flow for Malware Detection and Analysis, Research Showcase @ CMU, Carnegie Mellon University, 2007. |
Hiroshi Shinotsuka, Malware Authors Using New Techniques to Evade Automated Threat Analysis Systems, Oct. 26, 2012, http://www.symantec.com/connect/blogs/, pp. 1-4. |
Idika et al., A-Survey-of-Malware-Detection-Techniques, Feb. 2, 2007, Department of Computer Science, Purdue University. |
Isohara, Takamasa, Keisuke Takemori, and Ayumu Kubota. “Kernel-based behavior analysis for android malware detection.” Computational intelligence and Security (CIS), 2011 Seventh International Conference on. IEEE, 2011. |
Kaeo, Merike , “Designing Network Security”, (“Kaeo”), (Nov. 2003). |
Kevin A Roundy et al: “Hybrid Analysis and Control of Malware”, Sep. 15, 2010, Recent Advances in Intrusion Detection, Springer Berlin Heidelberg, Berlin, Heidelberg, pp. 317-338, XP019150454 ISBN:978-3-642-15511-6. |
Khaled Salah et al: “Using Cloud Computing to Implement a Security Overlay Network”, Security & Privacy, IEEE, IEEE Service Center, Los Alamitos, CA, US, vol. 11, No. 1, Jan. 1, 2013 (Jan. 1, 2013). |
Kim, H. , et al., “Autograph: Toward Automated, Distributed Worm Signature Detection”, Proceedings of the 13th Usenix Security Symposium (Security 2004), San Diego, (Aug. 2004), pp. 271-286. |
King, Samuel T., et al., “Operating System Support for Virtual Machines”, (“King”), (2003). |
Kreibich, C. , et al., “Honeycomb-Creating Intrusion Detection Signatures Using Honeypots”, 2nd Workshop on Hot Topics in Networks (HotNets-11), Boston, USA, (2003). |
Kristoff, J. , “Botnets, Detection and Mitigation: DNS-Based Techniques”, NU Security Day, (2005), 23 pages. |
Lastline Labs, The Threat of Evasive Malware, Feb. 25, 2013, Lastline Labs, pp. 1-8. |
Li et al., A VMM-Based System Call Interposition Framework for Program Monitoring, Dec. 2010, IEEE 16th International Conference on Parallel and Distributed Systems, pp. 706-711. |
Lindorfer, Martina, Clemens Kolbitsch, and Paolo Milani Comparetti. “Detecting environment-sensitive malware.” Recent Advances in Intrusion Detection. Springer Berlin Heidelberg, 2011. |
Marchette, David J., “Computer Intrusion Detection and Network Monitoring: A Statistical Viewpoint”, (“Marchette”), (2001). |
Moore, D. , et al., “Internet Quarantine: Requirements for Containing Self-Propagating Code”, INFOCOM, vol. 3, (Mar. 30-Apr. 3, 2003), pp. 1901-1910. |
Morales, Jose A., et al., ““Analyzing and exploiting network behaviors of malware.””, Security and Privacy in Communication Networks. Springer Berlin Heidelberg, 2010. 20-34. |
Mori, Detecting Unknown Computer Viruses, 2004, Springer-Verlag Berlin Heidelberg. |
Natvig, Kurt , “SANDBOXII: Internet”, Virus Bulletin Conference, (“Natvig”), (Sep. 2002). |
NetBIOS Working Group. Protocol Standard for a NetBIOS Service on a TCP/UDP transport: Concepts and Methods. STD 19, RFC 1001, Mar. 1987. |
Newsome, J. , et al., “Dynamic Taint Analysis for Automatic Detection, Analysis, and Signature Generation of Exploits on Commodity Software”, In Proceedings of the 12th Annual Network and Distributed System Security, Symposium (NDSS '05), (Feb. 2005). |
Nojiri, D. , et al., “Cooperation Response Strategies for Large Scale Attack Mitigation”, DARPA Information Survivability Conference and Exposition, vol. 1, (Apr. 22-24, 2003), pp. 293-302. |
Oberheide et al., CloudAV.sub.—N-Version Antivirus in the Network Cloud, 17th USENIX Security Symposium USENIX Security '08 Jul. 28-Aug. 1, 2008 San Jose, CA. |
Reiner Sailer, Enriquillo Valdez, Trent Jaeger, Roonald Perez, Leendert van Doorn, John Linwood Griffin, Stefan Berger., sHype: Secure Hypervisor Appraoch to Trusted Virtualized Systems (Feb. 2, 2005) (“Sailer”). |
Silicon Defense, “Worm Containment in the Internal Network”, (Mar. 2003), pp. 1-25. |
Singh, S. , et al., “Automated Worm Fingerprinting”, Proceedings of the ACM/USENIX Symposium on Operating System Design and Implementation, San Francisco, California, (Dec. 2004). |
Thomas H. Ptacek, and Timothy N. Newsham , “Insertion, Evasion, and Denial of Service: Eluding Network Intrusion Detection”, Secure Networks, (“Ptacek”), (Jan. 1998). |
U.S. Appl. No. 17/146,417, filed Jan. 11, 2021 Final Office Action dated Feb. 14, 2023. |
U.S. Appl. No. 17/146,417, filed Jan. 11, 2021 Non-Final Office Action dated Nov. 17, 2022. |
U.S. Appl. No. 17/146,417, filed Jan. 11, 2021 Non-Final Office Action dated Jun. 13, 2023. |
Number | Date | Country | |
---|---|---|---|
62316427 | Mar 2016 | US | |
62316390 | Mar 2016 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15258656 | Sep 2016 | US |
Child | 17087550 | US |